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ABSTRACT 
This dissertation describes the interactions of nitric oxide (NO) and C-
nitrosoalkanes (RNO) with group 8 and 9 metalloporphyrins and heme proteins. The 
goal of this research is to provide new information on the coordination chemistry of NO 
and NO-related compounds.  
Chapter 1 introduces the biological role of nitric oxide (NO), the application of 
heme models, and previous research on the C-nitrosoalkane adducts of 
metalloporphyrins from our former group members and others.  
Chapter 2 describes the synthesis and structural characterization of 
nitrosoamphetamine and N-hydroxyamphetamine adducts of group 8 & 9 
metalloporphyrins. The reactivity of selected complexes was studied. Density functional 
theory calculations were also conducted on selected structurally characterized 
metalloporphyrin-nitrosoamphetamine and metalloporphyrin-N-hydroxyamphetamine 
complexes, and the data were compared to the experimental results.  
Chapter 3 focuses on the coordination chemistry of C-nitroso compounds with 
heme proteins. In this chapter, the first crystal structures of hemoglobin (Hb) in 
complex with nitrosoalkanes are presented, along with sperm whale H64A myoglobin 
(Mb) in complex with NOAmph. The two structures of the Hb-nitrosoalkane proteins 
surprisingly revealed insight into the Hb degradation process induced by organic C-
nitroso complexes. The structure of sw H64AMb(NOAmph) displayed an unexpected 
orientation of the NOAmph ligand in the heme pocket.  
Chapter 4 describes the interactions between NO and d6 group 9 
metalloporphyrins. In this work, a series of d6 group 9 metalloporphyrins were 
 xiii 
synthesized and structurally characterized. They were used as precursors for the 
reactions with NO gas. The first known molecular structures of rhodium nitrosyl 
porphyrins are described, as well as the first observation of a NO insertion into a metal-





Chapter 1. Introduction 
Nitric oxide (NO) is a simple diatomic molecule. It has received great research 
attention in the last two decades for its biological roles in vasodilation and 
neurotransmission in mammals.1-3 The most important biological reaction of NO is 
perhaps its interaction with heme proteins. NO is biosynthesized by a heme-containing 
enzyme, NO synthase.4 As a signaling agent in vasodilation, NO stimulates a heme 
containing protein, namely soluble guanylyl cyclase (sGC), through binding with the 
heme group of this enzyme.5,6 The most intensively studied interaction between NO and 
heme proteins is the coordination of NO to the metal centers of these proteins.7-10 Due 
to the complexity of the protein-NO interaction and the difficulties of obtaining protein 
crystal structures, much of the research on the interactions between NO and heme 
proteins is complemented by using synthetic metalloporphyrins as heme models.11-15  
 
Figure 1.1. The molecular orbital diagram of NO.  
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It is important to note that NO is a free radical. As shown in Figure 1.1, the π* 
orbital of NO is singly occupied.  When NO bonds with a transition metal complex, 
there is a back-donation of electron density from the metal d orbital into the π* 
antibonding orbital of NO, this results in a weakening of the N-O bond which lowers 
υNO in the IR spectrum.    
Iron protoporphyrin IX (PPIX) (Figure 1.2), also known as heme b, plays an 
important role in biology. It is the iron-containing cofactor of myoglobin (Mb) and 
hemoglobin (Hb) proteins.16 The propionate groups of PPIX participate in important 
hydrogen bonds with solvent (water) and some amino acids near the distal pockets of 
Mb and Hb. 17 
                                      
Figure 1.2. The structure of heme b (iron protoporphyrin IX).  
	  
Heme is produced in nature through a complex eight-step biosynthetic pathway 
involving multiple enzymes.18,19 However, this asymmetric porphyrin is difficult to 
synthesize in the laboratory. Consequently, a series of symmetrical and hydrophobic 
porphyrins have been synthesized and utilized by bioinorganic chemists as models for 
heme. The known synthetic iron porphyrins used in this dissertation include the octa-β-
substituted 2,3,7,8,12,13,17,18-octaethylporphyrin (OEPH2) (Figure 1.3, top left), the 
 3 
tetra-meso-substituted 5,10,15,20-tetraphenylporphyrin (TPPH2) (Figure 1.3, top right) 
and the tetra-meso-substituted 5,10,15,20-tetra(p-methoxyphenyl)porphyrin (T(p-
OMe)PPH2) (Figure 1.3, bottom). 
 
Figure 1.3. Synthetic iron porphyrin complexes used in this work.  
	  
Our group is interested in the chemistry of NOx species. One branch of our 
research is the study of the interaction of C-nitroso compounds with metal porphyrins 
and heme proteins. The C-nitroso compounds, as shown in Figure 1.4, have the general 
formula RNO (R= aryl or alkyl). The nitroso moiety in these molecules is valence 
isoelectronic with dioxygen, and displays strong binding affinity towards the metal 
 4 
centers of porphyrins. Studies in the early 1970s on C-nitroso compounds revealed that 
they are toxic substances and play important physiological roles in biology. A variety of 
RNO compounds have been demonstrated to react with heme proteins such as 
myoglobin (Mb), hemoglobin (Hb) and cytochrome P450 to form stable complexes that 
consequently result in the inhibition of these heme proteins.20-22 In addition, the 
formation of nitrosobenzene from the oxidative metabolism of aniline was found to 
induce methemoglobinemia and hemolytic anemia in animals.23,24  
 
Figure 1.4. The structure of C-nitroso compounds. 
Interestingly, all of the above-mentioned reports on the interactions of C-nitroso 
compounds with proteins were investigated using only UV-vis spectroscopy. No 
structural information was available at that time to reveal how RNO ligands coordinate 
with the metal center of heme proteins. In 1983, Mansuy prepared and structurally 
characterized the first metalloporphyrin-RNO complex, (TPP)Fe(iPrNO)(iPrNH2).25 
This work established the N-binding mode of the RNO compound to the ferrous 
porphyrin (Figure 1.5, left).  
Our group started to work on C-nitroso compounds in 1996. Our group 
demonstrated, by X-ray crystallography, that nitrosoarenes can bind to metal porphyrins 
through multiple modes (Figure 1.5).26 While the d6 (TPP)FeII(PhNO)2 displayed an N-
binding mode of the nitrosoarene, the d5 [(TPP)FeIII(Et2NC6H4NO)2]SbF6 displayed the 
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hitherto unreported O-binding mode of a nitrosoarene. The same O-binding mode was 
observed in the structure of a d4 MnIII porphyrin complex, namely 
[(TPP)Mn(ONC6H4NEt2)2]SbF6, published by our group. 27 To date, these are the only 
two known O-binding C-nitroso metal porphyrin complexes reported in the literature. 
All other reactions of RNO (R = phenyl, tolyl, isopropyl) with d6 FeII, RuII, OsII and 
CoIII porphyrins resulted in the formation of N-binding complexes.28-30 The binding 
mode of the RNO complex is quite an interesting topic, since it could help us to 
understand how the C-nitroso ligands approach the heme center in the heme proteins.  
                                 
Figure 1.5. Two binding modes of RNO to metalloporphyrins.  
	  
In 2002, our group started to work on the structures of C-nitroso adducts of 
heme proteins.31 At the time, there was only one reported heme-nitrosoarene structure, 
namely that of legHb(PhNO) from Lupinus luteus.32 In 2003, a member from our group 
who was jointly supervised by Dr. West, Daniel Copland, published the first crystal 
structure of a heme protein complexed to a nitrosoalkane, namely horse heart 
Mb(EtNO).31 In both the structures of legHb(PhNO) and Mb(EtNO), the RNO ligand 
bound with the heme center through the N atom as observed in the model complexes of 
d6 metal porphyrins.  
 6 
 My dissertation research consists of two main areas. In Chapters 2 and 3, I 
present my work on the interactions of C-nitroso compounds with synthetic 
metalloporphyrins and heme proteins. In Chapter 4, I present my work on the 
coordination chemistry of the NO molecule with d6 group 9 metal porphyrins.   
Chapter 2 focuses on a physiologically important, but structurally 
uncharacterized, C-nitroso compound nitrosoamphetamine (NOAmph), which is the N-
oxidized derivative of amphetamine. A series of NOAmph adducts of 
metalloporphyrins were synthesized and structurally characterized, and the reactivity of 
selected complexes have been studied. The information I obtained fills in a gap of 
knowledge in the coordination chemistry of C-nitroso compounds such as 
nitrosoamphetamine.  
In Chapter 3, I extend the studies to the interactions between C-nitroso 
compounds and heme proteins. I collaborated with two of our group members, Dr. Jun 
Yi and Bing Wang, to obtain the first crystal structures of a nitrosoalkane binding to Hb 
and of NOAmph binding to sperm whale (sw) H64AMb. The two structures of the Hb-
nitrosoalkane proteins gave us insight into the Hb degradation process induced by 
organic C-nitroso complexes. The structure of NOAmph binding sw H64AMb also 
displayed an unexpected orientation of the NOAmph ligand in the heme pocket.  
Chapter 4 describes my work on a previously unknown area in the coordination 
chemistry of NO with metal porphyrins. In this work, I managed to prepare and 
structurally characterize the first reported rhodium nitrosyl porphyrins, which displayed 
weak NO binding and unexpected long Rh-N(O) bond distances. I also observed, for the 
 7 
first time, an NO insertion into a metal-carbon bond in any porphyrin system, which led 
to the formation of a C-nitroso ligand.  
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Chapter 2. Reactions between N-hydroxyamphetamine and 
metalloporphyrins: synthesis, characterization and computational 
studies 
2.1 Introduction 
The coordination chemistry of C-nitroso (RNO, R = alkyl, aryl) compounds with 
transition metal porphyrins and proteins containing the heme group is a research interest 
of our group. The nitroso group on RNO compounds is isoelectronic with dioxygen, and 
has a high affinity to the metal center of some porphyrins.1 Such affinity remains in the 
biological environment, which enables the efficient binding of RNO compounds 
towards the heme center in heme proteins.2-4 As a result, the RNO compounds are 
known to be actively involved in various harmful biological metabolic processes, 
including the nitrobenzene poisoning,5,6 the inhibition of cytochrome P450 enzymes3,7 
and the degradation of hemoglobins (discussed in Chapter 3).8 To make things worse, 
the nitroso compounds can be generated from the metabolism of amine- and nitro-
containing drugs. There is also an increased effort in the exploration of RNO 
compounds as NO donors for biological studies.9 Thus, understanding the fundamental 
chemistry of C-nitroso binding to metal porphyrins becomes very crucial for drug 
design.10   
RNO binding with metalloporphyrins has previously been extensively studied, 
including a series of (por)Fe(iPrNO)(L) (L=MeOH, py, 1-MeIm) complexes 
synthesized and characterized by our previous group member, Christal D. Sohl.11 
However, the structural studies are surprisingly limited to a small range of ligands. 
Most of the structures published to date show the binding of nitrosobenzene (PhNO) 
derivatives to the synthetic metalloporphyrins.12-15 There is only one nitrosoalkane 
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ligand involved in such studies, which is the above-mentioned 2-nitrosopropane 
(iPrNO). No drug-related nitrosoalkane compounds have previously been used in these 
kind of studies. Also, all the crystal structures of (por)Fe(iPrNO)(L) contain an organic 
base as a trans ligand on the other side of the porphyrin, which serves as an electron-
donating group,  thus enhancing the π-backbonding from the metal to the iPrNO. Efforts 
of making nitrosoalkane bound iron porphyrin complexes without a trans ligand, to the 
best of my knowledge, have been unsuccessful. More importantly, the structures 
involving C-nitrosoalkanes are all from the reactions with d6 Fe(II) porphyrins. Cobalt 
also plays a very important role in the biological environment. Surprisingly, however, 
the interactions of nitroso compounds with d7 Co(II) porphyrins have not yet been 
reported.  
Our work in this chapter is intended to fill in the gap in this area. We are 
interested in the reactions of iron/cobalt porphyrins with the nitroso derivative of a very 
important drug molecule, amphetamine (Amph). Amphetamine is known for its effects 
on elevating dopamine, norepinephrine and biogenic amines in human brain.16 It has 
been profoundly used as an illicit drug, and has also been applied to the treatment of 
children with attention deficit hyperactivity disorder (ADHD) and adults with 
narcolepsy.17,18 The metabolism of amphetamine has been wildly studied. N-
hydroxyamphetamine (AmphNHOH) was identified as one of the N-oxygenated 
metabolites of amphetamine in liver from early work.19-21 In a recent paper, human 
FMO3 was also reported to N-oxidize amphetamine and methamphetamine to 
AmphNHOH in vitro.22 After the generation of AmphNHOH, it could easily react with 
different heme proteins (Cytochrome P4502, PHGS4) to form stable Fe(II)-RNO 
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complexes  and lead to the inhibition of the enzyme activities. Although there are 
extensive studies on the reaction mechanisms of amphetamine and its derivatives, the 
determinants of pharmacological toxicity of amphetamine remain unclear. The 
amphetamine-induced release of serum myoglobin is proposed to be a biomaker of the 
toxicity of this drug.23 
2.2 Experimental section 
2.2.1 Materials, instrumentation, and methods 
The reactions were performed under anaerobic conditions using standard 
Schlenk techniques under an atmosphere of nitrogen and/or in an Innovative Technology 
Labmaster 100 Dry Box unless stated otherwise. Solvents used for the reactions were 
obtained from an Innovative Technology Pure Solv 400-5-MD Solvent Purification 
system under an atmosphere of nitrogen. A Bio-Rad FT-155 FTIR spectrometer was 
used to record the infrared spectra. Proton NMR spectra were recorded on Varian 
Mercury VX 300 MHz spectrometer or Varian VXR-S 400 MHz spectrometer for room 
temperature and low temperature experiments, and the signals were referenced to the 
solvent employed (CD3Cl at 7.24 ppm). UV-vis data was collected on an HP 8453 diode 
array instrument with a 1.0 cm cuvette. X-ray diffraction data were collected by Dr. 
Douglas R.Powell using a diffractometer with a Bruker APEX ccd area detector24,25 and 
graphite-monochromated Mo Kα radiation (λ = 0.71703Å).  
Density functional calculations (B3LYP/DGDVZP) were performed using 
Gaussian-0926 on the WebMO interface (https://webmo.oscer.ou.edu). Geometric 
optimizations, vibrational frequency calculations and molecular orbital calculations were 
performed for selected complexes: (porphine)Fe(1-MeIm)(NOAmph) (S = 0), 
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(porphine)Fe(NOAmph)-(AmphNHOH) (S = 0), (porphine)Fe(NOAmph)2 (S = 0), 
(por)Fe(NOAmph) (S = 0), (por)Co(AmphNHOH) (S = 1/2). 
Nitromethane (99.5%) and sodium borohydride (98.5%) were purchased from 
Sigma-Aldrich. N-butylamine (99%), benzaldehyde (99%), borane-tetrahydrofuran (1M 
solution in THF) were purchased from Aldrich Chemical Co. Anhydrous ethanol (ACS 
grade) was purchased from Pharmco-AAPER. Sodium bicarbonate was purchased from 
EM Science. Anhydrous magnesium sulfate (97%) was purchased from Mallinckrodt.  
Hydrochloric acid (37%) was purchased from EMD chemicals. Ether (anhydrous, 
99.9%) was purchased from J.T.Baker. THF, dichloromethane and hexane were 
collected from the solvent distillation system under nitrogen. 
 (OEP)FeCl and (TPP)Co were purchased from Midcentury Chemicals. ((p-
OMe)TPP)FeCl, (TPP)FeCl and (TPP)CoCl were prepared following literature 
methods.27 The purity of the synthesized complexes was ascertained by spectroscopy.  
2.2.2 Synthesis 
             1-Phenyl-2-nitropropene and N-hydroxyamphetamine were prepared following 
the literature methods with slightly modification.28,29 1-Phenyl-2-nitropropene was 
synthesized by reacting nitroethane (1.4 ml, 0.02 mol) with benzaldehyde (2.1 ml, 0.02 
mol) in anhydrous ethanol (5 ml) with the addition of butylamine (0.1 ml, 0.001 mol). 
The mixture was refluxed for 8 hrs and resulted in the formation of a large amount of 
pale yellow crystals during cooling on ice. The crystals were washed with water and 
methanol to remove the orange colored impurities. The yield of the product was 60% by 
weight. 1H NMR (CDCl3): 8.10 (s, 1H, CH), 7.44 (m, 5H, phenyl), 2.42 (s, 3H, CH3). 
The NMR spectrum is identical to that previously reported30.  
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N-hydroxyamphetamine was prepared from the reduction of 1-phenyl-2-
nitropropene with BH3⋅THF in a THF solution in the presence of a small amount of 
NaBH4 as catalyst.28 An oven-dried nitrogen-flushed Schlenk tube was cooled to 0 °C 
on ice. A BH3⋅THF (2.65 ml, 0.0027 mol) solution was added to Schlenk tube using a 
syringe under nitrogen. In another oven-dried nitrogen-flushed Schlenk tube, 1-phenyl-
2-nitropropene (0.45 g, 0.0027 mol) was dissolved in 9.5 ml THF. The solution of 1-
phenyl-2-nitropropene was slowly added to the BH3⋅THF solution cooled with ice bath. 
After addition was completed, the ice bath was removed, and a catalytic amount of 
NaBH4 (~40mg) was added into the mixture. The solution was kept stirring until the 
yellow color of the starting material turned clear. Ice water (40 ml) and 5.5 ml HCl 
(10%) were then added to the mixture. The mixture was refluxed at 65 °C for 2 hours 
and cooled to room temperature. The organic soluble compounds were extracted with 
ether and discarded. Sodium carbonate was added to remaining aqueous fraction to 
neutralize the solution. Solid NaCl was added to the solution until saturated. The 
products were extracted with ether in three cycles. Anhydrous MgSO4 was used to dry 
the extracts overnight and the solvent was removed under vacuum. The final yield of 
the product was 45% by weight of the white powdery product. The N-
hydroxyamphetamine was kept at -20 °C in glove box for several weeks showing no 
sign of decomposition. It will gradually decompose to a yellow liquid if kept at room 
temperature. 1H NMR (CDCl3): 7.19-7.32 (m, 5H, phenyl group), 3.21 (m, 1H, CH), 
2.65 (dd, 1H, CH2), 2.85 (dd, 1H, CH2). We did not observe the protons on the –NHOH 
group. 
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(OEP)Fe(ONCH(CH3)CH2Ph)(1-MeIm) (1): Excess N-hydroxyamphetamine 
(0.037 g, 0.2 mmol) was added to a stirred 5 mL solution of (OEP)FeCl (0.037 g, 0.06 
mmol) in CH2Cl2. The color of the solution changed from brown red to black purple 
during a 6 hour period. 1-MeIm (0.02 ml, 0.25 mmol) was added into solution and the 
mixture was stirred overnight. The solution was dried in vacuo and redissolved in a 
CH2Cl2/hexane (1:1) mixture. 1-MeIm (0.01 ml, 0.125 mmol) was added to this solution. 
Purple plate-shaped crystals formed during slow evaporation of the mixture in the dry 
box at room temperature. The isolated yield of the crystals was 58%.  IR (KBr, cm-1): 
νNO = 1419 s; also 1559 m, 1507 m, 1457 s, 1374 w, 1337 w, 1251 m, 1224 m, 1143 m, 
1107 s, 1085 w, 1018 s, 955 s, 829 m, 745 s, 700 s.  1H NMR (CDCl3): 9.73 (s, 4H, 
meso-H of OEP), 3.93 (q, 16H, CH2CH3 of OEP), 1.82 (t, 24H, CH2CH3 of OEP), 6.78 
(m, p,m-H of phenyl group), 5.78 (d, 2H, o-H of phenyl group), -0.578 (m, 1H, CH2), -
1.58 (q, 1H, CH), -1.74 (d, 1H, CH2), -2.525 (d, 3H, CH3). The peaks of 1-MeIm were 
not observed at room temperature, but could be observed in the NMR spectrum at lower 
-40 oC.  1H NMR (CDCl3, -40 oC): 4.55 (s, 1H of 1-MeIm), 1.90 (s, overlapping with 
CH2CH3 of OEP, CH3 of 1-MeIm), 0.95 (s, 1H of 1-MeIm), 0.6 (s, 1H of 1-MeIm). 
Attempted preparation of (OEP)Fe(ONCH(CH3)CH2Ph)(MeOH)(2): A mixture 
of (OEP)FeCl (0.037 g, 0.06 mmol) and N-hydroxyamphetamine (0.037 g, 0.2 mmol) in 
a 5 ml CH2Cl2/CH3OH (2:1) solution was stirred for 6 h, during which time the solution 
changed to a reddish purple color. The solution was dried in vacuo to give a solid 
tentatively identified as (OEP)Fe(ONCH(CH3)CH2Ph)(MeOH). The slow evaporation 
method with a CH2Cl2/MeOH solution did not grow X-ray quality crystals (78% 
isolated yield of the micro crystals). IR (KBr, cm-1): νNO = 1425 s; also 1657 w, 1546 w, 
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1495 w, 1453 s, 1375 s, 1298 m, 1268 s, 1226 w, 1146 s, 1110 m, 1057 s, 1016 s, 987 m, 
957 s, 835 s, 744 s, 699 s.  
Attempted preparation of (OEP)Fe(ONCH(CH3)CH2Ph)2 (3): A mixture of 
(OEP)FeCl (0.015 g, 0.024 mmol) and N-hydroxyamphetamine (0.037 g, 0.2 mmol) in 
CH2Cl2 was stirred overnight, during which time the color changed from purple to black. 
The solution was dried in vacuo to give a solid tentatively identified as 
Fe(OEP)(ONCH(CH3)CH2Ph)2 . The residue was dissolved in a hexane/ CH2Cl2 mixture. 
The slow evaporation method did not yield X-ray quality crystals. IR (KBr, cm-1): νNO = 
1497 s; also 1453 s, 1377 s, 1318m, 1268 s, 1214 w, 1147 s, 1015 s, 983 w, 958 s, 915 
m, 848 m, 744 s, 701 s.  
(T(p-OMe)PP)Fe(ONCH(CH3)CH2Ph)2 (4)  : Excess N-hydroxyamphetamine 
(0.04 g, 0.22 mmol) was added to a 5 ml CH2Cl2 solution of (T(p-OMe)PP)FeCl (0.02 g, 
0.02 mmol). The solution was stirred overnight (~12hr) and taken to dryness in vacuo. 1 
ml CH2Cl2 was added to dissolve the red residue, followed by the careful layering of 8 
ml on top of the CH2Cl2 solution. Purple block-shaped crystals formed at the bottom of 
solution within two weeks (35% isolated yield of crystals). IR (KBr, cm-1): νNO = 
1505cm-1; also 1456 m, 1451 m, 1348 m, 1304 w, 1287 w, 1247 s, 1174 s, 1106 w, 
1076 w, 1030 m, 999 s, 955 w, 809 m, 743 s, 700 s. 1H NMR (CDCl3): 8.70 (s, 8H, 
pyrrole-H of T(p-OMe)PP), 7.95 (d, 8H, o-H of T(p-OMe)PP), 7.20 (m, meso-H of T(p-
OMe)PP, overlapped with CH2Cl2), 6.90 (m, 6H, p,m-H of phenyl group), 5.72 (d, 2H, 
o-H of phenyl group), 5.41 (d, 2H, o-H of phenyl group), 4.07 (s,12H, OCH3 of T(p-
OMe)PP), -0.7 (b, 2H, CH2), -1.5 (m, 1H, CH), -1.90 (b, 2H, CH2), -2.27 (d, 3H, CH3). 
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Peaks of the second nitrosoamphetamine ligand were not clearly observed at room 
temperature.   
(T(p-OMe)PP)Fe(ONCH(CH3)CH2Ph)2 (4) and (T(p-
OMe)PP)Fe(ONCH(CH3)CH2Ph) (5): The synthesis procedure was identical to the one 
just described for compound (T(p-OMe)PP)Fe(ONCH(CH3)CH2Ph)2. The crystal 
structure of the final product indicated that it was a mixture of both five and six 
coordinate complexes. IR (KBr, cm-1): νNO = 1505 cm-1, 1434 cm-1; Also 1606 s, 1574 
w, 1539 m, 1454 m, 1386 w, 1348 s, 1286 m, 1245 s, 1174 s, 1106 w, 1072 w, 1036 w, 
995 s, 850 w, 798 s, 741 w, 715 m, 696 m, 606 s. 1H NMR (CDCl3): 8.72 (s, 8H, 
pyrrole-H of T(p-OMe)PP),7.98 (d, 8H, o-H of T(p-OMe)PP),7.30 (m, meso-H of T(p-
OMe)PP, overlapped with CH2Cl2), 4.11 (s, 12H, OCH3 of T(p-OMe)PP), 6.93 (m, 6H, 
p,m-H of phenyl group), 5.77 (d, 2H, o-H of phenyl group), -0.26 (t, 1H, CH2), -0.93 (b, 
1H, CH), -1.47 (d, 1H, CH2), -2.21 (d, 3H, CH3). Peaks of the second 
nitrosoamphetamine ligand were not clearly observed at room temperature.  
(TPP)Fe(ONCH(CH3)CH2Ph)(NHOHCH(CH3)CH2Ph) (6): Excess N-
hydroxyamphetamine (0.015 g, 0.1 mmol) was added into to a stirred 5 ml CH2Cl2 
solution of (TPP)FeCl (0.015 g, 0.02 mmol). The solution was reacted overnight (~12 
hr), during which time the color changed from yellow/red to red/purple. The product 
was taken to dryness in vacuo and the residue was re-dissolved in 1 ml of CH2Cl2. 6 ml 
of hexane was then careful layered on the top of the CH2Cl2 solution in Schlenk tube. 
Block-shaped black crystals were formed at the bottom of the solution after two weeks 
(40% isolated yield of crystals). IR (KBr, cm-1): νNO = 1435; also 1599 s, 1538 w, 1494 
s, 1453 s, 1349 m, 1303 m, 1259 m, 1204 w, 1177 w, 1073 m, 1002 s, 796 m, 744 s, 700 
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s. 1H NMR (CDCl3): 13.40 (b, H of NH), 12.00 (b, H of OH), 8.64 (pyrrole-H of TPP), 
7.97 (o-H of TPP), 7.60 (p, m-H of TPP), 6.84 (p, m-H of phenyl group), 5.64 (o-H of 
phenyl group), -0.61 (H of CH2), -1.61 (H of CH), -2.35 (H of CH3). 
 (TPP)Fe(ONCH(CH3)CH2Ph)(1-MeIm) (7): To a solution of Fe(TPP)Cl (0.02 g, 
0.028 mmol) was added N-hydroxyamphetamine (0.02 g, 0.13 mmol) followed by the 
addition of 1-MeIm (0.01 ml, 0.125 mmol). The color of the solution changed from 
yellow red to dark red after overnight stirring. The solution was taken to dryness in 
vacuo. Attempted crystallization of the residue in a solution of CH2Cl2/hexane did not 
yield good quality crystals.  IR (KBr, cm-1): νNO = 1430; also 1496 s, 1453 s, 1375 s, 
1362 w, 1284 w, 1258 w, 1223 m, 1203 w, 1159 w, 1110 s, 1091 w, 1069 w, 1032 s, 
1001 m, 995 m, 966 s, 901 s, 877 w, 824 s, 795 m, 739 s, 699 s.  
(TPP)(Fe)(1-MeIm)2•2(1-MeIm) (8): A crystal of Fe(TPP)(1-MeIm)2•2(1-MeIm) 
was obtained serendipitously as follows: To a 10 mL CH2Cl2 solution of (TPP)FeCl 
(0.010 g, 0.014 mmol) was added N-hydroxyamphetamine (0.07 g, 0.05 mmol) and 1-
MeIm (0.05 ml, 0.6 mmol). After 6 hours of reaction, the solution was dried under 
reduced pressure. The red purple residue was re-dissolved in CH2Cl2, and an equal 
volume of hexane was added. Red plate-shaped crystals grew from the slow evaporation 
of this mixture in the glove box.  The isolated yield of crystals is 50%.  
(TPP)Co(NHOHCH(CH3)CH2Ph) (9): Excess N-hydroxyamphetamine (0.03 g, 
0.2 mmol) was added into a stirred CH2Cl2 solution of (TPP)CoCl (0.015 g, 0.02 mmol). 
The solution changed from red purple to an orange color after an overnight reaction. 
The product was taken to dryness in vacuo and the residue was washed with methanol. 
The slow evaporation of a CH2Cl2/hexane (2:1) solution of the residue in the glove box 
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resulted in the formation of cubic brown crystals within one week. The yield is 55% as 
estimated from 1H NMR spectroscopy.  1H NMR (CDCl3): 15.60 (b, 8, pyrrole H of 
TPP), 12.73 (b, 8, o-H of phenyl group), 9.78 (m, p-H of phenyl group), 9.55 (m, m-H 
of phenyl group), 9.12~8.91 (d, pyrrole H of TPP), 8.16 (m, o-H of phenyl group), 7.77 
(m, p, m-H of TPP), -0.92 (b, CH2), -2.70 (b, CH3), -4.61 (b, CH), -5.60 (b, NH). 
2.3 Results and discussion 
2.3.1 Synthesis 
 Our research group previously reported the preparation and characterization of 
some iron porphyrin nitrosoarene/alkane complexes.  They were prepared via one of 
two main methods as shown in eqs. 2.1 and 2.2.  The first method involves the direct 
coordination of the nitrosoarene ligand to the ferrous center in the metalloporphyrin 
(Eq. 2.1). 
                
 





The second method involves a redox reaction between a ferric porphyrin and an 
alkylhydroxylamine (Eq. 2.2); the ferric center is reduced by the ligand, and the ligand 
is oxidized in the process to the nitroso derivative that binds to the metal.  Since the 
alkylhydroxylamine oxidation is formally a two-electron oxidation, it is not surprising 
that the yield of the product is not quantitative; as there are other minor uncharacterized 
products from the reaction. 
 In my desire to prepare the previously unreported nitrosoamphetamine 
derivatives of iron porphyrins, I noted that the "free" nitrosoamphetamine ligand is 





Consequently, it was impractical for me to attempt to utilize the first preparative 
method for the synthesis of the Fe-nitrosoamphetamine complexes.  Utilization of the 





In the case of the representative compound 1 (Eq. 2.4; where por = OEP), the 
reaction in the presence of 1-methylimidazole proceeded over a 6-12 hour period during 
which time the color of the solutions due to the precursor (por)FeCl changed to a black-
purple color.   Work-up of the product resulted in its isolation in ~58% yield.  I was 
unable to characterize any side-product of this reaction despite several attempts to do 
so.  When the reaction was carried in the presence of methanol (in place of 1-MeIm), a 
product tentatively formulated, based on its IR spectrum, as the 
(OEP)Fe(NOAmph)(MeOH) was obtained.  In the absence of any secondary axial 
ligand, I had hoped to generate and crystallize the bis-nitrosoAmph derivative.  A 
product was obtained that could be formulated as the anticipated target compound 
(based in IR spectroscopy). However, I was not successful in crystallizing it for a 
structural study. 
 Fortunately, when the p-methoxy-substituted porphyrin (por = T(p-OMe)PP) 
was utilized for the reaction of the ferric precursor with the N-hydroxyamphetamine 
reagent, I was able to generate and isolate the final bis-nitrosoamphetamine product 
shown in eq. 2.5.  It is likely, based on the results from related reactions (see below), 
that the initial product is the six-coordinate nitroso/hydroxylamine-coordinated complex 
shown at top right of eq. 2.5.  However, I was not able to isolate this intermediate 
compound, but I note that the final crystalline product isolated in 35% yield was 






I was surprised that I could also obtain a crystalline sample as shown by X-ray 
crystallography to be a mixture of the six-coordinate product of eq. 2.5 and its 5-
coordinate partner (namely with only one coordinated nitrosoAmph ligand).  It is likely 
that very minor differences in the crystallization/experimental conditions provided this 
new crystal structure; I discuss this in more detail in the section on crystallography. 
 When the parent tetraphenylporphyrin macrocycle (por = TPP) is used for the 
reaction described in eq. 2.4 (i.e., in the presence of 1-MeIm), I was able to obtain the 
TPP analogue of the product.  Curiously, when the same reaction was performed with a 
large excess of 1-MeIm, I obtained, after workup of the product mixture, crystals of the 
ferrous bis-imidazole compound (TPP)Fe(1-MeIm)2.   
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 It is interesting to note that in the absence of the added 1-MeIm as axial base, I 
obtained and successfully isolated the nitrosoAmph/hydroxylamineAmph product that 





 Cobalt(III) is isoelectronic with ferrous Fe(II).  I was thus curious whether the d6 
Co(III) ion would be able to oxidize the AmphNHOH ligand in the same way as the d5 
Fe(III) ion did to form the NOAmph derivative.   In the reaction between AmphNHOH 
with a Co(III) porphyrin, I saw no evidence for coordinated NOAmph in the products, 
although reduction to the Co(II) species (with or without AmphNHOH) did occur (eq. 
2.7), as determined by UV-vis spectroscopy and by X-ray crystallography (see later).  
The (TPP)Co(AmphNHOH) complex was unstable in air, as determined by UV-vis and 





2.3.2 Spectroscopy  
The organic nitroso moiety in the generated R-N=O ligand renders itself 
amenable to vibrational spectroscopic analysis.  In general, such NO vibrations (υNO) 
occur in the 1300 cm-1 ~1500 cm-1 range for metal-coordinated nitrosoalkanes.  This 
spectral range is normally unobstructed by porphyrin macrocycle vibrations, although 
on occasion the NO vibrations overlap with porphyrin bands. 
 In general, the υNO's of the iron-coordinated nitrosoamphetamine complexes 
obtained in this chapter fall into the 1510-1410 cm-1 range.  The υNO of the 
(OEP)Fe(NOAmph)(1-MeIm) (1) complex as a KBr pellet occurs at 1419 cm-1 (Figure 
2.1, bottom) which is close to the υNO's of 1423 cm-1 reported for a related secondary 
nitrosoalkane complex (OEP)Fe(i-PrNO)(1-MeIm) reported previously from our 
laboratory.   
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Figure 2.1. IR spectra of the precursor (OEP)FeCl (top) and the (OEP)Fe(NOAmph)(1-
MeIm) product (1: bottom) as KBr pellets. 
	  
Selected chemical drawings from my work and their associated υNO's are 
presented in Figure 2.2.  When the axial 1-MeIm ligand of 1 is replaced with MeOH, 
the υNO shifts upward to 1425 cm-1, a feature indicative of the greater electron donation 
to the iron center by 1-MeIm compared with the solvent MeOH.  The lower overall 
electron donation by the axial MeOH ligand reduces the electron density at the metal 
center, which in turn, reduces the metal-to-RNO backbonding into the π* orbital of the 
nitroso moiety, thus strengthening this bond and raising its υNO.  This 1-MeIm and 
MeOH comparison is consistent with that observed for the i-PrNO analogue as well. 
Interestingly, when the β-octasubstituted OEP porphyrin macrocyle is replaced 
with the less electron-rich meso-tetrasubstituted TPP macrocycle, the υNO's of the      
NOAmph ligand also increases from 1419 cm-1 in (OEP)Fe(NOAmph)(1-MeIm) (1) to 
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1430 cm-1 in (TPP)Fe(NOAmph)(1-MeIm) (7; not shown in Figure 2.2), again 
indicative of a lower metal-to-ligand back-donation in the case of the TPP analogue.  
 
  
Figure 2.2.  Chemical drawings of selected product complexes and their IR υNO bands. 
	  
  I also note that replacement of the 1-MeIm ligand in 7 with the N-
hydroxylamphetamine ligand (i.e., compound 6 in Figure 2.2) results in a further 
increase of the υNO by 5 cm-1, suggesting that the 1-MeIm ligand is an overall better 
electron-donor that the RNHOH moiety.  In fact, this observation is consistent with the 
fact that the mixed ligand RNO/RNHOH complex is not isolated from any of the 
reactions when 1-MeIm was present in the reaction mixture. 
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 Although I was able to obtain crystalline samples of the bis-NOAmph 
compound 4 (por = T(p-OMe)PP), I was fortunate to also obtain one such sample that 
contained a mixture of the five-coordinate (T(p-OMe)PP)Fe(NOAmph) (5) and the six-
coordinate 4 (see middle boxed area in Figure 2.2).  Importantly, the structure of 5 
represents the very first reported five-coordinate iron porphyrin nitrosoalkane/arene 
complex for any porphyrin in the literature. The large differences in the observed υNO's 
of the five-coordinate 5 (1434 cm-1) and the six-coordinate 4 (1505 cm-1) is attributed to 
the π acidity of RNO ligands due to the electronegativity of the "NO" moiety as well as 
the availability of the π* orbital in this moiety that can accept electron density from the 
metal.  Thus, placing two π-acid RNO ligands in a mutually trans position effectively 
reduces the electron density at the metal center, with a resulting decreased back 
donation into the RNO π* orbitals, thus significantly raising υNO. But why is there such 
a large υNO difference of 71 cm-1 in the case of the mono-NOAmph complex 5 vs. the 
bis-NOAmph complex 4, whereas there is a smaller ΔυNO of 26 cm-1 when comparing 
the mono-PhNO vs. bis-PhNO in the Ru derivatives shown at bottom of Figure 2.2. I 
believe that the answer lies in the orientations of the axial ligand planes; this is 
discussed further in the section on the X-ray crystal structures.  
 The iron nitrosoamphetamine complexes obtained in this chapter contain π-acid 
RNO moieties that are in strong analogy to carbon monoxide (CO), thus are at the high 
end of the spectrochemical series.  It is therefore not surprising that they end up being 
low-spin ferrous d6 compounds, hence are diamagnetic and readily amenable to 1H 
NMR spectroscopic characterization.  Many of the compounds I attempted to obtain 
throughout my studies with the amphetamine derivatives ended up not being very pure, 
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as judged by 1H NMR spectroscopy.  Consequently, I focused on additional 
purifications using crystallization of the target compounds, and then redissolving those 
crystals in deuterated chloroform for the 1H NMR spectroscopic work.  The 1H NMR 
spectroscopic data for representative example, namely for 1, is shown in Figure 2.3.  
The spectrum of this compound, as with the spectra of the others, displayed 
characteristic peaks for the porphyrin macrocycles (in the boxed area of Figure 2.3), 
thus we will not discuss these macrocycle proton peaks further. 
 
Figure 2.3.  Sketch of compound 1 and its associated 1H NMR spectroscopic data. 
	  
Two important features stand out from Figure 2.3.  First, the 1H NMR signals 
between the nitroso and phenyl groups of the coordinated NOAmph ligand are upfield 
from the "normal" 0-10 ppm range for diamagnetic complexes.  This is attributed to the 
ring current effect of the aromatic porphyrin macrocycle.  In fact, similar upfield shift of 
1H NMR spectral peaks have been noted for other complexes such as (por)Rh(R)  and 
(por)Co(t-Bu) (see Chapter 4).    
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 Another interesting observation is that the 1H NMR spectral signals for the axial 
1-MeIm ligand are not discernable in the room temperature (~20 °C) spectra, but 
become readily discernable at lower temperatures (e.g., at -40 °C).  This is likely due to 
a fast equilibrium between the coordinated and uncoordinated 1-MeIm at room 
temperature that broadens the peaks such that they are not readily observed.  Cooling 
down the 1H NMR sample stabilizes the six-coordinate form and allows the observation 
of the 1-MeIm signals.  A similar phenomenon has been previously reported by a 
former group member during her work with the (por)Fe(iPrNO)(1-MeIm) complexes.11  
 The 1H NMR spectrum of the complex mixture 5/4 (namely (T(p-
OMe)PP)Fe(NOAmph) + (T(p-OMe)PP)Fe(NOAmph)2; boxed area in Figure 2.2) was 
quite interesting.  Although we determined, by X-ray crystallography, that there were 
two compounds in this mixture, the solution 1H NMR spectrum at room temperature 
appeared to show the presence of only one species, namely that of the five-coordinate 5.  
This observation is, however, consistent with what I saw for the six-coordinate 1-MeIm 
compounds described in the previous paragraph, that the 1H NMR signals for the sixth 
axial ligand were not observable at room temperature in solution. To ensure that our 
assignments of the 1H NMR peaks for the NOAmph ligands were indeed correct in this 
complex mixture 5/4 (namely (T(p-OMe)PP)Fe(NOAmph) + (T(p-
OMe)PP)Fe(NOAmph)2; boxed area in Figure 2.2), I embarked on 2D 1H NMR 
spectroscopy in collaboration with Dr. Susan Nimmo.   The COSY and HSQCAD 





    Figure 2.4.   The COSY spectrum of the (T(p-OMe)PP)Fe(NOAmph) + (T(p-







Figure 2.5.   The HSQCAD spectrum of the (T(p-OMe)PP)Fe(NOAmph) + (T(p-





Figure 2.6.   The HSQCAD spectrum of the (T(p-OMe)PP)Fe(NOAmph) + (T(p-





In the COSY spectrum (Figure 2.4), a coupling interaction between the proton 
signals at 6.93, 5.77 and 5.61 ppm (the latter two overlapping in the 1D spectrum) was 
observed, which corresponds to the coupling of the o-H, and p,m-H of the phenyl group 
of the NOAmph ligand and confirms their assignment.   The two HSQCAD spectra 
shown differ in the ppm ranges in the horizontal (1H) and vertical (13C) axes.  The 
HSQCAD spectrum in Figure 2.5 shows the signals in the range of 5.0 ppm to 9.0 ppm 
that are assigned to the porphyrin macrocycle and the phenyl group of the ligand. The 
2D NMR spectrum indicated that the signal at 6.93 ppm and 5.77 ppm belong to the 
protons on the phenyl group of the ligand. 
 The HSQCAD spectrum focusing on the 0 ppm to -2.5 ppm range is shown in 
Figure 2.6.  I had initially assigned, from the 1D NMR spectrum, the triplet at -0.28 
ppm and the doublet at -1.50 ppm to the protons of the methylene (β-carbon) group.   In 
this 2D experiment, I confirmed that these two protons were bonded to the same carbon 
atom (at 37.1 ppm in the 13C NMR spectrum).  The 1H NMR signal at -2.21 ppm is 
assigned to the methyl H group on the α-C atom, and this correlates with the 13C signal 
of this α-C at 13.06 ppm.  A 1H NMR signal at -0.93 ppm is assigned to the H on the α-
C atom, and this correlates with the 13C signal of the α-C at 88 pm; this 13C downfield 
shift is normal for C-nitroso compounds even without the metal.31 Importantly, what 
was clear from the 1D and the 2D NMR spectra was the apparent 1:1 integration ratio of 
the NOAmph 1H signals to the porphyrin macrocyle. Similar to that observed in the 1-
MeIm six-coordinated derivatives, when the 1D NMR spectrum of the 5/4 mixture is 
collected at lower temperatures, additional signals at -0.6 (d), -1.7 (s), and -2.02 (s) ppm 
become apparent; this observation likely due to the stabilization of the six-coordinate 4 
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at lower temperatures.  However, we were not able to definitively assign these signals in 
the absence of 2D spectra at these lower temperatures.  In addition, the compounds were 
not very stable in solution, as judged by the gradual disappearance (e.g., overnight at 
room temperature) of the α-CH signals in the 1H NMR spectra. 
 1H NMR spectroscopy also confirmed the identity of the sixth ligand in the 
(TPP)Fe(NOAmph)(AmphNHOH) compound 6 (Figure 2.2).  In addition to the 
macrocyle peaks, signals at 6.84 (s), 5.64 9s), -0.61 (br), -1.62 (d), and -2.36 (s) ppm 
were observed for the coordinated ligand.  Furthermore, two upfield and broad peaks at 
13.40 and 12.20 ppm were observed and assigned to the protons on the -NHOH moiety 
of the sixth AmphNHOH ligand; such peaks were not observed in any of the NOAmph 
complexes discussed earlier. 
 I mentioned earlier that the cobalt complex (TPP)Co(AmphNHOH) was 
unstable in air.  The following UV-vis spectra illustrate this point.  The addition of 
AmphNHOH to an aerobic (TPP)CoCl solution ( λmax 406 nm; not shown) led to the 
reduction of the Co(III) reagent to a Co(II) product, as determined by the initial 
generation of a typical Co(II) spectrum with a Soret band at 410 nm and a visible band 
at 530 nm (Figure 2.7).25 The smaller peak at ~434 nm is due to a new Co(III) species.  
When 1-MeIm was added to the solution and the solution allowed to stir overnight, the 
band at 432 nm grew in intensity and became the dominant band in the spectrum 
(Figure 2.7; dashed line). This Soret band at 432 nm with visible bands at 548 and 585 
nm are consistent with the aerobic formation of the known CoIII(TpivPP)(1-MeIm)O2- 




Figure 2.7.  UV-vis spectra of the reaction between (TPP)CoCl and AmphNHOH in 
CH2Cl2 in air.  Solid line: spectrum of the initial product solution.  Dashed line: after 
addition of 1-MeIm and overnight stirring. 
	  
          To examine further the air-sensitivity of the (TPP)Co(AmphNHOH) complex, I 
dissolved a few crystals (from the same batch of crystals I used for the X-ray structural 
characterization) in CH2Cl2 in air, and recorded the UV-vis spectrum (Figure 2.8). The 
spectrum showed immediate (after ~5 min exposure to air) oxidation of the 
(TPP)Co(AmphNHOH) to the Co(III) derivative ( λmax 431 nm).  When the solution 
was left in air for ~8 hours, the 431 nm peak became the only prominent peak, 
indicating the high-yield conversion to the Co(III) product.  It has been reported 
previously that Co(II) porphyrins are easily oxidized to a stable 
bis(hydroxylamine)cobalt(III) complex with the addition of hydroxylamine in air.  The 
(TPP)Co(NH2OH)2 displays two bands at 427 nm and 542 nm.33  The red-shifted Soret 
band from 412 nm to 431 nm in this work strongly suggests the aerobic oxidation of 
Co(II) to a Co(III) complex.  The formation of Co(III) derivative in solution in air was 
also confirmed by an attempted 1H NMR spectral characterization of 
(TPP)Co(AmphNHOH) that showed the presence of a diamagnetic Co(III) species.  
Due to an apparent lack of a defined anion in solution, the anion of the oxidized Co(III) 
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product is likely to be superoxide.   I note that a similar spectrum change was observed 
previously during the introduction of O2 into a Co(II)(TpivPP) solution in the presence 
of 1-MeIm.32 
 
Figure 2.8.  Solid line: The UV-vis spectrum of a dissolved crystal of 
(TPP)Co(AmphNHOH) in CH2Cl2 in air. Dashed line: After leaving the solution in air 
for ~8 hrs. 
	  
2.3.3 X-ray crystallography  
 The metabolism of organic nitro or amine compounds involves the nitroso 





the experimental section, I utilized the hydroxylamino precursor in the reactions to 
isolate the ferrous NOAmph derivatives.  Although the IR and NMR spectral data were 
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consistent with the structures proposed in Figure 2.2 (e.g., observation of a υNO for the 
nitroso derivative), it is important that the identities of the products and proposed 
binding modes of the ligands be verified by determining their three-dimensional 
molecular structures using X-ray crystallography.  Several of the product complexes 
were crystallized and their solid-state crystal structures determined (Figures 2.9-2.13).  
The structure of (OEP)Fe(NOAmph)(1-MeIm) complex is shown in Figure 2.9 (top), 
and selected geometrical parameters are collected in Table 2.1.  The NOAmph ligand is 
bound to the ferrous center via the N-atom, a feature that is consistent with our previous 
finding that this N-binding mode enhances stability of the complex via efficient π-
backbonding from the ferrous center into the π* orbital of the nitroso ligand.  This is 
consistent with the slight upward displacement of the Fe atom towards the NOAmph 
ligand (by 0.05 Å; middle of Figure 2.9), with an Fe-N(O) bond length of 1.805(6) Å.  
The porphyrin macrocycle is saddled. 34 
 We also note that since the organic NOAmph molecule is unstable towards 
tautomerization to the oxime form (see earlier eq. 2.3), that the binding to Fe and 
subsequent π-backbonding interaction stabilizes this otherwise unstable 2° RNO 
compound.   Further evidence for the lack of tautomerization comes from the tetrahedral 
nature of the α-C atom (i.e., C32) bearing the N=O moiety (Figure 2.9); the unobserved 
(isomerized) oxime tautomer should have a planar α-C atom.   
 The axial NOAmph plane essentially bisects adjacent porphyin atoms as shown 
in at the bottom of Figure 2.9, with an O1-N7-Fe1-N3 torsion angle of 47°.  In contrast, 
the 1-MeIm plane is essentially coplanar with porphyrin diagonal N-atoms (i.e., N2 and 
N4; not shown); the angle between the 1-MeIm plane and the nearest Fe-N(por) bond is 
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2°.  Such axial ligand orientations have been observed previously in a few other 
complexes such as (OEP)Fe(i-PrNO)(1-MeIm).11 The axial Fe-N(1-MeIm) bond length 





Figure 2.9. (a) Molecular structure of (OEP)Fe(NOAmph)(1-MeIm).  The minor 
disordered components of the NOAmph ligand (~18%) are not shown.  Hydrogen atoms 
have been omitted for clarity. (b) Perpendicular atom displacements (in units of 0.01 Å) 
of the porphyrin core from the 24-atom mean porphyrin plane. (c) Top view from RNO 
ligand side. The phenyl groups and 1-MeIm ligand are omitted for clarity. 
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 The Ph moiety of the NOAmph ligand is oriented near-perpendicular at 73° to 
the porphyrin macrocycle. It is important to note that our complementary DFT 
calculations show two stable orientations of this Ph group, one near-perpendicular to the 
porphyrin macrocyle and one near-parallel as seen for the AmphNHOH derivatives in 
this work (see later). Importantly, Figures 2.9-2.12 represent the first reported crystal 
structures containing the biologically relevant NOAmph ligand.    
 The molecular structure of the bis-nitroso compound (T(p-
OMe)PP)Fe(NOAmph)2 (Figure 2.10) offers a nice comparison with that of 
(OEP)Fe(NOAmph)(1-MeIm) described above.  The (T(p-OMe)PP)Fe(NOAmph)2 
structure is the first bis-nitrosoalkane porphyrin structure to be reported.  In general, the 
NOAmph ligand conformation is similar to that observed in (OEP)Fe(NOAmph)(1-
MeIm).  The mutually trans π-accepting NOAmph ligands result, not too surprisingly, 
in weaker and longer Fe-N(axial) bonds (e.g., 1.955(2) Å in (T(p-
OMe)PP)Fe(NOAmph)2 (Table 2.1).  Consistent with this observation is the shorter 
nitroso N=O bond length of 1.242(3) Å in the bis-NOAmph derivative where the Fe 
center is less electron rich due to both axial ligands being electron-withdrawing, 
resulting in less π-backbonding from Fe to the NO π* orbitals.   This is also consistent 
with the IR spectroscopic data, namely a higher υNO for this bis-nitroso derivative, 
discussed in the previous section.  The porphyrin macrocycle adopts a wave-like 







Figure 2.10. (a) Molecular structure of (T(p-OMe)PP)Fe(NOAmph)2. Hydrogen atoms 
have been omitted for clarity. (b) Perpendicular atom displacements (in units of 0.01 Å) 
of the porphyrin core from the 24-atom mean porphyrin plane. (c) The top view 
showing the axial RNO ligand orientation. The i-methoxyphenyl and one of the 
NOAmph groups are omitted for clarity. 
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 Due to the uniqueness of the bis-nitroso structure reported in Figure 2.10, 
namely that this was the first such bis-nitrosoalkane structure, I pursued further studies 
with this compound to investigate its stability both in solution and in the solid-state.  As 
part of my detailed study, I was able to repeat the crystallization under what I felt were 
the identical conditions used earlier for the structure shown in Figure 2.10.  To my 
amazement, the resulting crystalline product from what I perceived to be the same 
reaction and crystallization conditions yielded the "expected" six-coordinate (T(p-
OMe)PP)Fe(NOAmph)2.  However, the occupancy of the sixth ligand, namely the 
second NOAmph ligand, was only ~77%, leading to the net presence of both the 
expected six-coordinate complex (as in Figure 2.8) as the major component (77%), and 
the unexpected five-coordinate (T(p-OMe)PP)Fe(NOAmph) as the minor component 
(23%) as shown in Figure 2.11.  Obtaining this structure shown in Figure 2.11 and 
identifying both the five- and six-coordinate forms substantiates the view that having 
two NOAmph ligands trans to the same metal center results in a weakening of the Fe-
axial ligand interaction.  We were unsuccessful on attempts to obtain sufficiently 
accurate metrical parameters for the five-coordinate component as a separate entity to 
compare with the structure shown in Figure 2.10. 
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Figure 2.11 (a) Molecular structures of the five-coordinate (T(p-OMe)PP)Fe(NOAmph) 
(top left; 23%) and the six-coordinate (T(p-OMe)PP)Fe(NOAmph)2 (top right; 77%) in 
the same crystal. Hydrogen atoms have been omitted for clarity. (b) Perpendicular atom 
displacements (in units of 0.01 Å) of the porphyrin cores from the 24-atom mean 
porphyrin planes. (c) The top view showing the RNO ligand orientation.  
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 I was also fortunate to obtain suitable crystals of the mixed nitroso-
hydroxylamine derivative (TPP)Fe(NOAmph)(AmphNHOH), and the crystal structure 
of this complex is shown in Figure 2.12.  Fortunately, the hydrogen atoms on the ligand 
N and O atoms were located on a difference map and are indicated at the top of Figure 
2.12.  The nitroso Fe-N5 distance is 1.8226(17) Å, whereas the hydroxylamino Fe-N6 
distance is 2.1405(17) Å.  The hydroxylamino N-O formal single-bond distance of 
1.432(2) Å is longer than the trans nitroso formal double-bond distance. These data also 
substantiate the formulation of this compound as a (por)Fe(RN=O)(L) species.  Three 
observations from this structure are noteworthy.  First, the hydroxylamino moiety is 
stabilized on the metal center by a hydrogen bond between the hydroxyl H-atom and a 
porphyrin N-atom, with an O...N distance of 2.963(2) Å; this probably also determines 
the orientation of the AmphNHOH ligand with respect to the metalloporphyin plane.  I 
note that the porphyrin N-atom in question (i.e., N4) is apically displaced towards the 
AmphNHOH ligand by 0.04 Å from the porphyrin plane (middle of Figure 2.12).  
Second, the relative orientation of the mutually trans NOAmph and AmphNHOH 
ligands suggest that this compound may be the likely precursor to the bis-nitroso 
(por)Fe(NOAmph)2 derivatives.   Third, the near-parallel (to the porphyrin macrocycle) 
orientation of the Ph group in the AmphNHOH ligand is notably different from the 
orientation of the Ph group in the trans NOAmph ligand.  DFT calculations support the 
stability of such a relative orientation.  Curiously, there are no iron porphyrin 







Figure 2.12. (a) Molecular structure of (TPP)Fe(NOAmph)(AmphNHOH). Hydrogen 
atoms have been omitted for clarity except those on the NHOH moiety. A hydrogen 
bond between the porphyrin N4 atom and the NOH proton (H2O) is represented by a 
dashed line. (b) Perpendicular atom displacements (in units of 0.01 Å) of the porphyrin 
core from the 24-atom mean porphyrin plane; the NOAmph ligand is closer to the 
reader. (c) Left: the top view from NOAmph side. Right: the top view from 







Figure 2.13 (a) Molecular structure of (TPP)Co(AmphNHOH). Hydrogen atoms have 
been omitted for clarity except those on the NHOH group. A hydrogen bond between 
the porphyrin N2 atom and the NOH proton (H1O) is represented by a dashed line. (b) 
Perpendicular atom displacements (in units of 0.01 Å) of the porphyrin core from the 
24-atom mean porphyrin plane. (c) The top view from AmphNHOH side. The 




I extended my investigations to utilize the Co(II) ion which has one more 
electron in its valence shell than the ferrous Fe(II) does.  My goal was to determine if 
the Co metal could also assist in the net formal oxidation of the AmphNHOH ligand to 
the nitroso NOAmph form during the binding events.  The only product I was able to 
obtain was that containing the AmphNHOH ligand (Figure 2.13), suggesting that Fe 
was overall more efficient in oxidizing AmphNHOH to its nitroso NOAmph form than 
Co was.  As noted also for the Fe case in Figure 2.12, the AmphNHOH ligand appears 
to be stabilized on the Co center via a H-bond to a porphyrin N-atom (top of Figure 
2.13) in this significantly ruffled porphyrin (middle of Figure 2.13). 
2.3.4 Density functional calculations 
 I performed DFT calculations at the B3LYP/DGDZVP level, using an 
unsubstituted porphine (por) ligand as the macrocycle for computational efficiency.   I 
wanted to determine if the calculations reproduced the geometrical patterns observed in 
the X-ray crystal structures of the NOAmph and AmphNHOH complexes.  Importantly, 
I also wanted to use the DFT results as a confirmatory tool for the IR υNO data and 
trends observed.   A summary of the results is displayed in Table 2.2.   
 The DFT results confirmed that these complexes were minima on their potential 
energy curves.  The N-binding of the ligands were also reproduced in accord with the 
structures obtained.  The axial ligand orientations also matched those determined by X-
ray crystallography.  For example, the top view (third column of Table 2.2) of 
(por)Fe(NOAmph)(1-MeIm) matched that seen for the crystal structure of 
(OEP)Fe(NOAmph)(1-MeIm) in Figure 2.9; i.e., the observed orientation (orientation 
1) in the crystal structure is a minimum energy structure.   There is an alternate phenyl 
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orientation in the NOAmph ligand (i.e., orientation 2) as shown by the second entry in 
Table 2.2.  Interestingly, this orientation that has the phenyl near-parallel to the 
porphine macrocyle is 8.6 kcal/mol lower in energy.  So why isn't this orientation 2 
observed in (OEP)Fe(NOAmph)(1-MeIm).  I note that the DFT calculations were 
performed essentially on isolated "gas phase" molecules, whereas the crystal structure 
obtained embodies various degrees of crystal packing effects.  These packing effects 
could influence the final orientation of the NOAmph ligand. 
 For the AmphNHOH complexs, we noted some rather unique H-bonding 
interactions involving the AmphNHOH proton and a porphyrin pyrrole N-atom (e.g., 
top of Figures 2.12 and 2.13).  These H-bonding interactions were reproduced well by 
the DFT calculations as shown for the (por)Fe(AmphNHOH)(NOAmph) complex in 
Figure 2.14 below.  It thus appears that this H-bonding interaction also determines the 
axial ligand orientation in these and related complexes. 
 
Figure 2.14. The hydrogen bonds between the porphyrin N4 atom and the NOH proton 
(H2O) in DFT calculation (left) and solid-state crystal structure (right) are represented 









The highest occupied molecular orbitals (HOMOs) of these complexes are 
porphine based as illustrated in Table 2.2, whereas the lowest unoccupied molecular 
orbitals (LUMOs) of the Fe derivatives have large NO contributions consistent with the 
availability of the π* orbitals on the NO fragment behaving as π-acids.  The exception 
for this pattern on the LUMOs is that for the Co complex, which does not contain the 
"oxidized" π-acid NOAmph ligand, but rather the AmphNHOH ligand. 
 The trend in the DFT-calculated υNOs follows the experimentally observed trend, 
namely that for the (por)Fe(NOAmph)(L) derivatives, the trend follows the overall 
basicity of L being 1-MeIm (1532 cm-1) < no ligand (1562 cm-1) < AmphNHOH (1564 
cm-1) < NOAmph (1582 cm-1).  
2.3.5 Additional reactivity studies 
When (OEP)Fe(NOAmph)(1-MeIm) was reacted with nitrosobenzene, the υNO 




Figure 2.15.  The IR spectra showing the υNO of the precursor (OEP)Fe(NOAmph)(1-
meIm) at 14119 cm-1 (dashed line) and the υNO of the product at 1336 cm-1 (solid line) 




To confirm the identity of the presumed (OEP)Fe(PhNO)(1-MeIm) product, I 
carried out the control reaction of (OEP)FeCl with NaBH4 in CH2Cl2 in the presence of 
1-MeIm and 2 equiv. of PhNO.  The color of the solution changed from brown-black to 
a pink-red color after an overnight reaction. The product with a υNO of 1336 cm-1 was 
consequently assigned to the (OEP)Fe(PhNO)(1-MeIm) product; this product has also 
been characterized by another group member by X-ray crystallography.  We thus 





If the reaction to prepare (TPP)Fe(NOAmph)(1-MeIm) is carried out in the 
presence of a large excess of 1-MeIm (~10x excess), the final product obtained is the 






Red plate-shaped crystals of this Fe(TPP)(1-MeIm)2.2(1-MeIm) product grew 
from its CH2Cl2/hexane solution.  The molecular structure of this compound is shown in 
Figure 2.16.  In this structure, the two 1-MeIm planes are mutually parallel. The 
projection of the axial ligand has a dihedral angle of 28° with the closest Fe-Np bond. 
 
 
Figure 2.16. Molecular structure of (TPP)Fe(1-MeIm)2. Hydrogen atoms and the two 
uncoordinated 1-MeIm molecules have been omitted for clarity. 
	  
I note that although ferrous (por)Fe(imidazole)2 species are excellent structural 
models for the reduced cytochromes utilized in biological electron-transfer reactions,24 
this is only the third ferrous (por)Fe(imidazole)2 structure ever to have been reported in 
the literature.36,37 
In this work, I successfully synthesized a series of NOAmph bound iron 
porphyrins complexes from the reactions between AmphNHOH and iron porphyrins in 
the presence or absence of organic bases. Selected complexes have been structurally 
characterized. We have obtained the first crystal structure of an amphetamine derivative 
of an iron porphyrin ((OEP)Fe(NOAmph)(1-MeIm)). We also successfully obtained the 
first crystal structure of a bis-nitrosoalkane coordinated iron porphyrin ((T(p-
OMe)PP)Fe(NOAmph)2). Unexpectedly, one of the crystal structures of showed the 
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presence of both (T(p-OMe)PP)Fe(NOAmph)2 (major) and the five-coordinate (T(p-
OMe)PP)Fe(NOAmph) (minor) in the crystal. Furthermore, from a study of the reaction 
of AmphNHOH with (TPP)FeCl, we obtained the first crystal structure of a 
hydroxylamine (NHOH) coordinated iron porphyrin complex. An unexpected hydrogen 
bond was observed between the hydroxyl H-atom on the ligand and a porphyrin N-
atom, which helped stabilize the hydroxylamino moiety and could possibly involve in 
the H-abstraction process to form the NOAmph derivative.  
We also extended our investigations to the reaction of AmphNHOH with 
(TPP)CoCl. A single crystal of the five-coordinated (TPP)Co(AmphNHOH) was 
isolated from the product,  and the structure showed a similar H-binding to that 
observed in the structure of (TPP)Fe(AmphNHOH). The reaction of AmphNHOH with 
(Por)Co(III) was further studied by UV-vis spectroscopy. The stabilities and reactivities 
of selected NOAmph binding metal porphyrins have also been investigated and are 
reported. Our structural and spectroscopic studies on the NOAmph binding heme model 
complexes will not only fill in the gap of C-nitroso compounds coordination chemistry, 
but will also help to understand the reactivity of amphetamine derivatives in heme 
proteins.   
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Chapter 3. Spectroscopic studies and structural characterizations of 
RNO adducts of human hemoglobins and the NOAmph adducts of sw 
Mb H64A complex 
3.1 Introduction 
Organic C-nitroso compounds (RN=O; R = alkyl, aryl) form from the metabolic 
activation of their corresponding amine or nitro precursor drugs.  For example, 
nitrosomethane (MeN=O) is generated from the metabolic activation of aziridine-based 
antitumor drugs.1 N-hydroxyamphetamine (AmphNHOH) is generated from the N-
oxidization of amphetamine (Amph),2,3 and further reacts with cytochrome P4504-6 and 
prostaglandin H synthase (PGHS)7 to form nitrosoamphetamine (NOAmph).  It is also 
known that the metabolic activation of aniline (PhNH2) in rats results in the production 
of PhNO/PhNHOH.8 These C-nitroso metabolites are toxic to cells. They inhibit the 
function of the important cytochrome P450 enzymes9-11 and mitochondrial respiration in 
living cells, and covalently modify the βcys93 residue of human Hb.12 In addition, it is 
now known that the PhNO metabolite generated from the initial interaction of aniline 
with red blood cells results in increased Fe deposition in the spleen, and induces 
methemoglobinemia and hemolytic anemia in the animal.13 Importantly, the molecular 
mechanisms for the degradation and denaturing of Hb by RNO compounds remain 
unknown. There is also an increased interest in the design of RNO compounds as NO 
donors for biological studies,14 making it even more important to study the underlying 
mechanisms of their toxicity towards heme proteins and red blood cells.15  
Despite numerous spectroscopic studies on the interactions of C-nitroso 
compounds with heme proteins, very little structural information is known regarding the 
resulting heme-RNO products. Prior to my work in this area, there were only two heme-
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RNO structures published in the literature, namely those of horse heart Mb(EtNO)16 and 
the monomeric legHb(PhNO) from Lupinus luteus.17  
Our work in the first half of this chapter provides insight into the molecular 
pathway responsible for Hb degradation by C-nitroso compounds. In the second half of 
this chapter, we extend our work to a more physiologically important drug, 
amphetamine (Figure 3.1, left).  
       
Figure 3.1. The structures of amphetamine, N-hydroxyamphetamine and 
nitrosoamphetamine. 
	  
The function and metabolism of amphetamine was introduced briefly in Chapter 
2. We were interested in the AmphNHOH/NOAmph derivatives generated from the 
metabolism of amphetamine in vitro. The NOAmph compound (Figure.3.1, right) 
containing a phenyl group attached to the β-carbon is more bulky than the simple RNO 
compounds. In fact, prior to our work in this chapter, it was assumed that 
AmphNHOH/NOAmph could only react with heme proteins with very large active sites, 
such as cytochrome P450 and PHGS. It was thought that heme proteins with smaller 
active sites (e.g. Hb and Mb) could not form stable NOAmph-FeII protein complexes 
with amphetamine derivatives.7 
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3.2 Experimental section 
3.2.1 Materials, instrumentation and methods 
Human blood was obtained from the Emergency Room at the University of 
Oklahoma Medical Center in Oklahoma City. The required training allowing me to 
handle blood was completed prior to me handling the blood. The oxyHb was separated 
from the blood cells, and the subsequent purification was performed using published 
methods with slight modification.18,19 The purified protein was concentrated 
to140mg/mL and frozen in liquid N2 prior to storage at -80 °C. Horse heart met-
myoglobin (hh metMb) was purchased from Sigma. Ferric swMbH64A and its crystals 
were kindly provided by Bing Wang of our laboratory.  
Monobasic sodium phosphate, dibasic sodium phosphate, sodium hydrosulfite, 
sodium chloride and sodium borohydride (98.5%) were purchased from Sigma. EDTA 
(disodium salt), nitromethane (99.5%), nitroethane (99.5%), 1-nitropropane (98%), 2-
nitropropane (97%), n-butylamine(99%), benzaldehyde (99%), 1-propanol (99.7%) and 
borane-tetrahydrofuran (1M solution in THF) were purchased from Aldrich. Anhydrous 
ethanol (ACS grade) was purchased from Pharmco-AAPER. THF was collected from a 
solvent distillation system (Innovative Technology, Inc. Newburyport, MA, USA, PS-
4000-5MD) under nitrogen.  
1-phenyl-2-nitropropene and N-hydroxyamphetamine were prepared using the 
same procedures described in Chapter 2. 1-phenyl-2-nitropropane was prepared by 
literature method.20 
UV-vis spectroscopy experiments were carried out on a Hewlett Packard 8453 
spectrophotometer equipped with a diode array detector. X-ray diffraction data sets 
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were collected on our home source RigakuMSC RU-H3R X-ray generator operated at 
50 kV/100 mA to produce Cu/Kα radiation (λ = 1.5418 Å).   
3.2.2 The preparation of metHb from oxyHb 
MetHb was prepared from the oxidation of oxyHb.18 1.2 fold of potassium 
ferricyanide was slowly added into an oxyHb solution in phosphate buffer on ice over a 
5~10 min period. A color change of from red to dark red was observed. The mixture 
was then dialyzed in 20 mM phosphate buffer at pH 6.8 to remove the excess salt. The 
mixture was then centrifuged at 12000g for 5 min to remove any degraded protein. The 
formation of metHb was determined by UV-vis spectra from the Soret, α-, and β- bands. 
The extinction coefficient of metHb at 500 nm was used to calculate the concentration 
of protein.18  
3.2.3 UV-vis spectral studies of the reactions of nitroalkanes with hemoglobins in 
the presence of a reducing agent 
The reactions between nitroalkanes and hemoglobin in the presence of a 
reducing agents were examined for both oxyHb and metHb. The experiments were 
carried out in 3 mL quartz cuvettes and monitored by UV-vis spectroscopy. To a 2 mL 
solution of protein (7.5 µM in 100 mM phosphate buffer containing 1 mM EDTA at pH 
7.4) was added a ~20 fold excess of sodium dithionite (0.01 M, 30 µL), followed by the 
addition of 30 - 40 µL of the nitroalkane solution (nitroalkanes were diluted 2~fold in 
methanol). The nitroalkanes used for the experiments include nitromethane, nitroethane, 
1-nitropropane and 2-nitropropane. The spectra were collected aerobically at room 
temperature (~21°C).  The sodium dithionite solution was prepared freshly before each 
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reaction. The stock solution of protein was kept on ice during the experiment to 
minimize decomposition. 
In a control experiment, sodium dithionite was added to the protein solution 
prior to the addition of the nitroalkanes. The results did not show significant differences 
between these two methods in the generation of the final products. 
3.2.4 Crystallization of Hb(RNO) derivatives 
For the preparation of Hb(RNO) complexes, sodium dithionite (~100-150 mg) 
and the respective nitroalkanes RNO2 (R = Me, Et; 50 µL) were added to a solution of 
purified human metHb (30-40 mg/mL; phosphate buffer, pH 6.8).  The mixture was 
kept at 4 °C for 4-5 h, centrifuged, and the precipite was discarded.   
Crystals of the Hb(RNO) derivatives were obtained using the batch method 
according to published procedures for Hb derivatives.19 Several pH conditions in the 
5.6–7.0 range were achieved by varying the volume ratios of sodium phosphate 
(monobasic; 3.2 M) to potassium phosphate (dibasic; 3.2 M).  100 µL of protein 
solutions (40 mg/mL) were added into various amounts (0.18–0.38 mL) of phosphate 
buffer as well as 1–2 drops of toluene in 3 mL-sized vacutainer tubes.  The protein 
solutions were mixed gently by slowly inverting the stoppered vacutainer tubes.   
Diamond shaped crystals of the Hb(RNO) (R = Me, Et) products started forming after 
~3 days.  Suitably sized Hb(RNO) crystals were harvested using cryo-loops, soaked in 
the mother liquid containing 16% glycerol for 5 min, and then flash-frozen in liquid 
nitrogen prior to data collection. 
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 3.2.5 X-ray diffraction data collection and processing (with Dr. Jun Yi) 
Data collection and structure solutions were performed in collaboration with Dr. 
Jun Yi. 
  X-ray data were collected at 100 K on the homesource RigakuMSC RU-H3R 
X-ray generator operated at 50 kV/100 mA to produce Cu/Kα radiation ( λ = 1.5418 Å).  
For the Hb(MeNO) structure, 0.5o oscillation images were collected over a range of 
100o with an exposure time of 5 min/image and a crystal-to-detector distance of 160 
mm.  For the Hb(EtNO) structure, 0.5o oscillation images were collected over a range of 
145o with an exposure time of 5 min/image and a crystal-to-detector distance of 160 
mm.  Diffraction data were indexed and processed with the d*TREK program 
(Macintosh v.99D).21 
In general, the phase information was obtained using the molecular replacement 
method as implemented in PHASER (v1.3.3).22  The search model was the 1.8 Å 
resolution structure of human Hb nitrite (PDB access code 3D7O)23 with all solvent 
molecules and nitrite ligands removed.  For the Rfree calculation, 5% of randomly 
selected reflections were flagged and carried throughout the complete refinement 
procedure.  The CCP4 program REFMAC 24 and the PHENIX 25 refinement program 
were utilized for structure refinement.  Bulk-solvent modeling and isotropic scaling of 
the observed and calculated structural amplitudes were used during the restrained 
refinements.  COOT 26 was used for visualization and model building/corrections 
between refinement cycles.  Water molecules were added to the structures using the 
"Update Waters" command in PHENIX at the later steps of refinements.   
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Hb(MeNO):  The initial electron density map after molecular replacement 
revealed the presence of V-shaped Fe-bound ligands in the sixth positions for both 
alpha and beta subunits.  The MeNO ligands were modeled into these V-shaped electron 
densities with the central N atom bound to Fe in both heme active sites.  The 
nitrosomethane ligand file was imported from the monomer library implemented in the 
CCP4 suite with a molecular code of NSM.  The Fe–N(nitrosomethane) bond distance 
and angle parameters were unrestrained throughout refinements; however, internal 
restraints of 1.22(2) Å (for d(N–O)), 1.45(2) Å (for d(C–N)) and 120(3)° (for ∠CNO) 
were applied to the nitrosomethane group.  In addition to the axial ligands, three 
glycerol molecules were modeled into the crystal lattice based on the electron density 
map.  The C-terminus residue of Arg141 in the alpha subunit was omitted from the 
structural model due to the poor electron density.  The final crystallographic R and Rfree 
of the human Hb(MeNO) structure are 0.22 and 0.28, respectively, in the 21.43–2.05 Å 
range. 
Hb(EtNO):  The initial electron density map revealed an axial ligand bound to 
heme Fe in the alpha distal pocket.  The nitrosoethane ligand was modeled into this 
electron density map via the N atom bound to heme Fe.  The crystallographic 
information file of nitrosoethane ligand was imported from the monomer library 
implemented in the CCP4 suite with a molecular code of NOE.  The Fe–
N(nitrosoethane) bond distance and angle parameters were unrestrained throughout 
refinements; however, internal restraints of 1.22(2) Å (for d(N–O)), 1.45(2) Å (for 
d(C2–N)) and 120(3)° (for ∠C2NO) were applied to the nitrosoethane group.  One 
 64 
glycerol molecule was modeled in the crystal lattice located at the interface of two 
subunits.    
The electron density map of the beta heme moiety was not as clear as that in the 
alpha subunit.  In addition to the expected heme position, there was new electron 
density beneath the distal His63 sidechain that showed a weak interaction with the NƐ 
atom of this residue.  To evaluate the likelihood that the extra density was due to a 
subpopulation of heme Fe, the SFTool and FFT programs in CCP4 were used to 
calculate the Fe anomalous signals for this structure.  In the anomalous map, there were 
two positive electron densities with an intensity ratio of 1:1, thus confirming that these 
signals were both from Fe in two positions [Fe1 for the “original” heme site, and Fe2 for 
the shifted heme that was shifted ~5.0 Å from its original position].  The original heme 
was removed from the structural model to recalculate an unbiased difference electron 
density map for the beta heme site.   Two heme molecules were modeled into the 
difference density map with 50% occupancy per molecule guided by the iron anomalous 
map as well.  There was no defined electron density showing axial ligand binding due to 
EtNO in the beta subunit.   
The C-terminus residue Arg141 in the alpha subunit was omitted from the 
structural model due to the lack of electron density.  The final crystallographic R and 
Rfree (for the final model) of the human Hb(EtNO) structure were 0.23 and 0.27, 
respectively, in the 21.4–2.0 Å range. 
The 2Fo–Fc electron density maps and the Fo–Fc electron density maps were 
generated using FFT as implemented in CCP4.  The figures of electron density maps 
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and the final model of the heme site of the human Hb(RNO) structures were drawn 
using PyMOL.  
 
Table 3.1.  X-ray data collection and refinement statisticsa 
 
 
 Hb(MeNO) Hb(EtNO) 
Data Collection   
PDB accession code 4M4A 4M4B 
Space group P41212 P41212 
Unit cell dimensions (Å) 53.57, 53.57, 191.87 53.44, 53.44, 193.58 
Resolution range (Å) 21.43-2.05 21.4-2.0 
Number of observations 110487 203574 
Unique reflections 18023 19790 
Average multiplicity 6.13(6.44) 10.29(7.05) 
Completeness (%) 97.7(92.9) 99.4(93.5) 
<I/σ(I)> 9.2(4.8) 22.1(5.8) 
Rmergeb 0.087(0.23) 0.044(0.274) 
   
Refinement   
Number of protein atoms 2266 2180 
Number of heteroatoms 168 218 
R-factorc 0.224 0.229 
Rfreed 0.28 0.270 
Average B-factor (Å2)e 33.68 53.86 
rms deviationsf   
     bond lengths (Å) 0.01 0.01 
     bond angles (o) 1.1 1.23 
Ramachandran plot (%)g   
    favored 97.9 97.52 
    outliers 0 0 
    rotamer outliers 0 0.87 
a The data in brackets refer to the highest resolution shell. 
b Rmerge = ƩƞklƩi |Ii(hkl)– <I(hkl)>|/ƩƞklƩi Ii(hkl),  where Ii(hkl) is the ith used 
observation for unique hkl, and <I(hkl)> is the mean intensity for unique hkl. 
c R = Ʃhkl||Fobs|– |Fcalc||/Ʃhkl|Fobs|, where Fobs and Fcalc are the observed and 
calculated structure factors, respectively. 
d Rfree was calculated using 5% of the randomly selected diffraction data which 
were excluded from the refinement. 
e The average for the polypeptide atoms. 
f deviations from ideal values.27 




3.2.6 The UV-vis spectral studies of reactions between Mb and its mutant with 
amphetamine derivatives 
Both hh Mb and sw MbH64A were used for these experiments. Protein 
concentrations were calculated using the extinction coefficient of metMb of 9.47 mM-
1cm-1 at 505 nm.18 Both 1-phenyl-2-nitropropane and N-hydroxyamphetamine were 
used in these reactions. The experiments were carried out in a 3 mL quartz cuvette and 
monitored by the UV-vis spectroscopy. 
Reaction with 1-phenyl-2-nitropropane: 8 µL of 1-phenyl-2-nitropropane (half 
diluted in methanol) was added to a 2 mL of 7 µM hh Mb solution (100 mM phosphate 
buffer at pH 7.4), followed by an addition of freshly prepared sodium dithionite (0.02 M, 
20 µL) solution.  
Reaction with N-hydroxyamphetamine: N-hydroxyamphetamine (5 µL) was 
added to a 2 mL of 2.2 µM sw MbH64A solution (100 mM phosphate buffer at pH 7.4). 
The N-hydroxyamphetamine solution was prepared by dissolving 6 mg N-
hydroxyamphetamine into 1 mL phosphate buffer (100 mM, pH = 7.4). The ligand had 
poor solubility in water, thus the mixture of ligand/water was vortexed three times for 1 
min each to help the ligand dissolve. However, there were still white precipitates on the 
bottom of solution after vortexing. The clear supernatant on top was added into the 
protein solution and the spectra were recorded. 
For the examinations of the stability of the tentative nitrosoamphetamine-sw 
MbH64A complex, potassium ferricyanide (5 µL, 0.05 M) or sodium dithionite (30 µL, 
0.02 M) were added into the protein solution. The changes were monitored by UV 
spectroscopy.  
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3.2.7 Soaking of crystals of sw MbH64A with N-hydroxyamphetamine 
Crystals of met sw MbH64A in a hanging drop plate (2.4 M AmSO4, 1 mM 
EDTA, 100 mM Tris-HCl buffer, pH 9.0) were kindly provided by Bing Wang. The 
solution with crystals was pipeted into a 10 µL droplet of cryo solution (3.1 M AmSO4, 
1 mM EDTA, 10 % glycerin, 100 mM Tris-HCl buffer) on a glass slide. The droplet 
was washed with the same buffer with 10% glycerol several times and covered with 
mineral oil. Two methods were used for the addition of ligands. One was the addition of 
N-hydroxyamphetamine in powder form via a needle. The white powder floated on the 
surface of the droplet at the beginning and slowly dissolved after several hours. Another 
method was the addition of N-hydroxyamphetamine in methanol. The ligand solution 
was pipeted into the droplet. The dark red crystals gradually turned to pink during 
soaking. Suitably sized crystals with differing soaking times (4 hours to 2 days) were 
harvested with cryoloops and flash frozen in liquid nitrogen.  
3.2.8 X-ray data collection and processing (with Bing Wang) 
            Data collection and structure solutions were performed in collaboration with 
Bing Wang.  
The diffraction data was collected at 100 K at home source using a Rigaku RU-
H3R X-ray generator coupled to a R-axis 4++ image plate detector. The data was 
collected at 1o oscillation angles over a 100° range with a crystal-to-detector distance of 
110 mm, and an exposure time of 5 min. The data was processed using iMosflm and 
SCALA as implemented in the CCP4 program suite.  
The phase problem was solved by the molecular replacement method with 
PHASER (CCP4). The starting model used was wild type met swMb(H2O) at 1.5 Å 
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resolution (PDB code 2mbw). All water molecules and ligands were removed from the 
starting model.   
Refinement was performed with Refmac5 (CCP4 suite) and COOT. The initial 
10 cycles of restrained refinement were run with Refmac, and the R factor decreased 
from 0.355 to 0.275. The ligand (N-hydroxyamphetamine), sulfate ions, glycerol and 
water were added to the model based on the Fo-Fc electron density maps in the 
following refinement cycles.  One N-hydroxyamphetamine ligand, four sulfate anions 
and five glycerol molecules were eventually added into the model.  Two conformations 
of Lys87, Lys133, Lys145 and Gly153 were modeled with 50% occupancy for each 
conformation. The N-terminal residue methionine was omitted because of the lack of 
electron density. The final R factor and Rfree were 0.149 and 0.177, respectively.  
The model of N-hydroxyamphetamine was taken from our unpublished X-ray 
structure of (OEP)Fe(NOAmph)(1-MeIm) in Chapter 2. To perform restrained 
refinement in Refmac5, the atoms of N-hydroxyamphetamine were selected from the 
Pymol file and saved as another pdb file which was run in Prodrg (CCP4 suite) to 
generate the coordinates in a new pdb file and the topologies in a monomer library cif 
file.  
3.3 Results and discussion 
 The objective of this work was to study the reactions between Hb and a series of 
simple nitrosoalkanes (RNO; R = Me, Et, Pr, iPr) by UV-vis spectroscopy and X-ray 
crystallography to obtain insight into how the different R groups in these nitrosoalkanes 
affect the properties and reactivities of their Hb(RNO) adducts.  Mansuy and coworkers 
have reported the UV-vis spectral studies of these compounds previously.29 However, 
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no structural studies on these compounds had been reported prior to our work in this 
area. 
3.3.1 Spectroscopic studies of the formation of Hb(RNO) complexes 
Primary (1°) and secondary (2°) nitrosoalkanes are not stable as monomers,30 as 
they isomerize to their more stable oxime derivatives (middle of Scheme 3.1; with a 
generic 2° R'C(Me)HNO nitroso compound). Thus, the nitrosoalkanes used in my work 
could not be reacted directly with the Hb protein. In general, there are two synthetic 
routes used for the preparation of hemeprotein-RNO complexes. One of these methods 
utilizes the reactions between nitroalkanes (RNO2) and heme proteins in the presence of 
a reducing agent (left of Scheme 3.1).29  
 
 
Scheme 3.1. Synthetic routes for the preparation of hemeprotein-RNO complexes.     
     
The addition of excess sodium dithionite (as the reducing agent) into a mixture 
of ferric metHb and the RNO2 reagents generated the ferrous Hb and the nitrosoalkanes 
simultaneously, to result in the formation of the Hb(RNO) products.  Another method 
reported in the literature (and utilized in Chapter 2 of this thesis) is the direct interaction 
of a hemeprotein with the corresponding alkylhydroxyamine RNHOH (right of Scheme 
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3.1).9 Since these N-alkylhydroxylamines are less stable in air than the corresponding 
nitroalkanes, first method was utilized to prepare the Hb(RNO) derivatives.  
In general, a ~20 fold excess of sodium dithionite was added into an aerobic 
solution of oxyHb solution followed by an addition of the nitroalkane that was half-
diluted in methanol (to increase its solubility).  The same procedure was used when 
metHb was employed.  The order of addition of the reagents was altered in some of the 
experiments for the purpose of comparison. Although dithionite is known to cause Hb 
degradation over long exposure periods, no formation of precipitates was observed 
during the time course of the experiments below.   Dithionite is frequently employed to 
scavenge trace oxygen from solutions,18 and this feature of dithionite most likely 
explains why either oxyHb or metHb yield the same final Hb(RNO) products.  
Addition of nitromethane (MeNO2) to dithionite-reduced ferrous Hb ( λmax 430 
nm) generated a species with  λmax at 420 nm as shown in the UV-vis spectra in Figure 
3.2. We also observed the shifts of Q bands from 555 nm (due to ferrous Hb) to 545/560 
nm due to the product.  Importantly, the 420 nm species did not form when MeNO2 was 






Figure 3.2. UV-vis spectra showing the conversion of ferric aquometHb (dashed line;  
λmax 406 nm) to ferrous Hb (dotted line;  λmax 430 nm) and then to ferrous Hb(MeNO) 
(solid line;  λmax 420 nm).  [Hb] = 7.5 µM; 100 mM phosphate buffer, 1 mM EDTA, pH 
7.4. 
	  
A time-course experiment was performed for this reaction (Figure 3.3). For this 
experiment, the reaction was set to t = 0 at the time that nitromethane was added to the 
dithionite-reduced Hb ( λmax 430 nm).  As shown in Figure 3.3, the Soret peak of 
deoxyHb at 430 nm completely shifted to 420 nm within 90 sec, after which time the 
intensity of the peak at 420 nm no longer increased.  This indicated that the reaction 
was complete, but the reaction mixture was left to stand for a period of one hour to 
monitor any subsequent changes.  There were three isosbestic points in the spectra 
obtained for this reaction, which are labeled with arrows in Figure 3.3 at 407, 426 and 
456 nm. The presence of these isobestic points indicated that the reaction involved only 





Figure 3.3. The time-course monitoring of the conversion of ferrous Hb (blue line;  λmax 
430 nm) to ferrous Hb(MeNO) (orange line;  λmax 420 nm) by UV-vis spectroscopy. 
The first spectrum was taken at t = 0 s (when nitromethane was added), followed by 
spectral collection at 10 s, 20 s, 30 s and 90 s.  Isosbestic points are at 407, 426 and 456 
nm.  
	  
This 420 nm complex was stable for at least 4 days at 4 °C in air, showing no 
signs of significant decomposition to the ferric ( λmax 406 nm) or the oxy-Hb ( λmax 415 
nm) forms (Figure 3.4).  Due to the stability of this 420 nm complex, we determined 
that it should be feasible to crystallize pre-formed Hb(MeNO) from solution.   
 
Figure 3.4. The UV-vis spectra of Hb(MeNO) in solution showing no signs of 
significant decomposition after the solution was left in air for 4 days at 4 °C (100 mM 
phosphate buffer, 1 mM EDTA, pH 7.4). The solid line is the initial spectrum. The 
dotted line is the spectrum of the complex after the 4 day period.  
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The analogous reaction using nitroethane (EtNO2) resulted in the formation of a 
spectrum (Figure 3.5) similar to that of the product in Figure 3.2.  The reaction 
generated a product with  λmax at 421 nm and additional Q bands at 544 and 561nm.  
 
 
Figure 3.5. UV-vis spectra showing the conversion of ferric aquometHb (dashed line;  
λmax 406 nm) to ferrous Hb (dotted line;  λmax 430 nm) and then to ferrous Hb(EtNO) 
(solid line;  λmax 420 nm).  [Hb] = 6.6 µM; 100 mM phosphate buffer, 1 mM EDTA, pH 
7.4. 
	  
The reaction was complete in ~3 min, as determined by a lack of further change 
of the 421 nm peak intensity.  This is a relatively slow reaction compared to the 
previously described reaction with nitromethane (see above).  Furthermore, the 
Hb(EtNO) product complex was less stable than its MeNO analogue, showing signs of 
decomposition after the solution was left in air for 2 days at 4oC (Figure 3.6).  
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Figure 3.6. UV-vis spectra showing the decomposition of the product complex 
Hb(EtNO) at 420 nm. The dash line is the initial spectrum, and the solid line is the 
spectrum after 39 hours (100 mM phosphate buffer, 1 mM EDTA, pH 7.4). 
 
 
After two days of exposure of Hb(EtNO) to air, the appearance of a shoulder 
peak at ~410 nm as well as the shifts of the peaks in the visible region to 542 and 572 
nm were observed (Figure 3.6).  The positions of the new peaks in the visible region are 
the same as the Q bands of oxyHb (542, 577 nm), which indicate the possible formation 
of oxyHb in solution.  The instability of Hb(EtNO) was further demonstrated by X-ray 
crystallography, which will be discussed later in this chapter. 
We extended our work to other nitroalkanes with larger alkyl groups, including 
1-nitropropane and its isomer 2-nitropropane.  Not surprisingly, those two compounds 
showed even slower reactions with metHb.  The reaction involving 1-nitropropane was 
complete after only ~40 mins as determined by the lack of further change in the 419 nm 
peak intensity.  Similar to the Hb(EtNO) complex, this 419 nm product complex is not 
very stable, decomposing slowly over a ~12 hr period in air.  
When the more sterically hindered 2-nitropropane was used in the same reaction, 
the formation of an analogous 420/419 nm complex was not observed (Figure 3.7). 
 75 
Rather, the spectra showed a slow aerobic conversion of deoxyHb ( λmax 430 nm; 
prepared from metHb at 406 nm) to oxyHb with the formation of new peaks at 415, 542 
and 576 nm over a 1 hr period.  I thus speculate that after the addition of 2-nitropropane 
to the protein solution followed by its reduction to the secondary 2-nitrosopropane by 
dithionite, that the 2-nitrosopropane ligand competes with oxygen to bind the heme site, 
and that sterics favor O2 binding rather than the bulky 2-nitrosopropane ligand.  
 
Figure 3.7.  UV-vis spectral monitoring of the reaction between ferric aquometHb 
(black line;  λmax 406 nm) and dithionite to generate ferrous Hb (dotted line;  λmax 430 
nm), and its subsequent conversion to oxyHb (light green line;  λmax 415 nm) after the 
addition of 2- nitropropane.  [Hb] = 6.0 µM; 100 mM phosphate buffer, 1 mM EDTA, 
pH 7.4. 
	  
 Overall, both the rates and extent of formation of the Hb(RNO) derivatives 
from metHb followed the order MeNO2 > EtNO2 > PrNO2 > iPrNO2. This is seen in the 
initial slopes of the product spectra in Figure 3.8.  
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Figure 3.8. UV-vis spectral monitoring of the reactions between metHb and the various 
nitroalkanes in the presence of excess sodium dithionite.  
	  
 This result is consistent with that previously reported by Mansuy.29  In Chapter 2, 
we discussed nitrosoalkanes (RN=O) serving as π acids when they bind to the iron 
centers via their N-atoms.  It is thus not surprising that MeNO shows the highest affinity 
to the Fe center, since it has more π acid properties compared to its analogues (i.e., Me 
is the least electron-donating of all the alkyl groups used).  Also, since the reaction 
involves the movement of an external ligand into the heme active site, the 
nitrosoalkanes with shorter chains and more simple structures are likely better suited for 
efficient entry into the heme pocket.  
Since all these reactions involve an "A + B + C" pattern (A = Hb, B = dithionite, 
C = nitroalkane), we further studied these reactions by changing the order of addition of 
the three reagents.  We observed that the alternate addition of nitromethane to metHb 
followed by sodium dithionite resulted in the shifts of peaks to the Hb(RNO) product 
peaks at ~ 420, 543 and 572 nm.  Although the Soret band at ~420 nm, as previously 
stated, indicates the formation of the Hb(RNO) derivatives, the peak profiles in the 
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visible region indicate that some other Hb complexes such as oxyHb may also be 
present in the products.  Consequently, the addition of a reducing agent before addition 
of nitroalkanes were the preferred method to obtain the Hb(RNO) complexes in this 
work.  
The differences between oxyHb and metHb (as the source of Hb) in these 
reactions were also examined. No difference in regards to the rates and extents of 
formation of the Hb(RNO) products was observed.  
3.3.2 Spectroscopic studies of the formation of the Mb-nitrosoamphetamine 
complexes 
As noted in the Introduction, nitrosoamphetamine (NOAmph) is an oxidative 
metabolite formed from amphetamine binds to the Fe center in various heme proteins.  
In Chapter 2, we reported the successful generation and crystallographic 
characterization of several heme model Fe-nitrosoamphetamine (Fe-NOAmph) 
complexes.  Our three-dimensional structural results from Chapter 2 show that the 
NOAmph ligand binds to the Fe centers via the N-atoms.  I was thus curious whether 
this relatively bulky NOAmph ligand would be able to enter and bind to the Fe center in 
a heme protein such as Mb, especially since the 2° nitrosopropane ligand did not show 
observable binding to the heme site in Hb (see above section).  In fact, Mansuy and co-
workers studied the abilities of different heme proteins to bind with various bulky and 
hydrophobic nitrosoalkane ligands,7 and proposed that due to the relatively small active 
sites of Hb and Mb, that large/bulky and hydrophobic ligands (such as NOAmph) are 
far less likely to form FeII-RNO derivatives.   I thus extended our RNO binding studies 
to the NOAmph ligand.  
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For NOAmph reactions, I tried both synthetic routes shown in Scheme 3.1, 
using both 1-phenyl-2-nitropropane and N-hydroxyamphetamine as the NOAmph 
precursors.  Although AmphNHOH is less stable than 1-phenyl-2-nitropropane in 
solution, it is more hydrophilic than its nitroalkane derivative.  To further assist with the 
binding of this ligand to the Mb heme site, I not only used wt Mb for our reactions, but 
also a distal pocket mutant, swMbH64A.  In Chapter 2, the reactions between 
AmphNHOH and the ferric porphyrins were carried out in an anaerobic environment. 
However, I found that the reactions between AmphNHOH and Mb could occur 
aerobically.  One of the two reactions presented here involves the reaction between hh 
Mb with 1-phenyl-2-nitropropane (NO2Amph) in the presence of sodium dithionite. The 
other reaction is the one involving reaction between sperm whale (sw) MbH64A and 
AmphNHOH.  The UV-vis spectra of the products from both methods indicated 
successful formation of the hh Mb FeII –NOAmph complex in solution, although the sw 
MbH64A-NOAmph complex appeared to be more stable than the wild type hh Mb-
NOAmph analogue.  
As shown in Figure 3.9, the addition of excess sodium dithionite to wt hh 






Figure 3.9.  UV-vis spectra showing the conversion of ferric hhMb (black line;  λmax 
408 nm) to ferrous hhMb (blue line;  λmax 435 nm) and then to a putative hh 
Mb(NOAmph) complex (orange line;  λmax 426 nm). This 426 nm product 
converts/decomposes to a 422 nm (red line) complex over a two-day period.  [Mb] = 7.1 
µM; 100 mM phosphate buffer, 1 mM EDTA, pH 7.4. 
	  
When 1-phenyl-2-nitropropane (NO2Amph) was added into the solution 
containing hh deoxyMb, the Soret peak shifted to 426 nm over a 5-hr period. This new 
Soret peak is close to those of Mb/Hb(RNO) compounds (see earlier), suggesting the 
formation of the wt hh Mb(NOAmph) product.  However, the formation of new peaks 
in the visible region was not as clearly evident.  Although the peak at 555 nm (for 
deoxyMb) clearly decreased over the 5-hr reaction time period, along with the 
formation and slight increase of the peaks at 541 and 575 nm, a major peak in the 
visible region still remained at 555 nm indicative of unreacted deoxyMb.  The 541 and 
575 nm peaks increase over a two-day period, with concomitant decrease in the 555 nm 
peak and a broadening of the Soret band.  The broadness of the Soret peak was likely 
due to the re-appearance of a minor metMb peak at 408 nm (along with the appearance 
of a peak at 500 nm due to metMb).  I conclude that while wt hh Mb(NOAmph) forms 
in solution, it is not very stable and oxidizes to the metMb precursor in air.  The 
 80 
instability of wt Mb(NOAmph) is not really a surprise due to the bulkiness of the 
NOAmph ligand.  However, I was glad to see some Mb(NOAmph) formation given the 
relatively small size of the Mb active site pocket.   
An objective of this project was to obtain a crystal structure of an NOAmph 
ligand bound to Mb as this would provide some crucial insight into the nature of 
binding of this bulky, but physiologically relevant ligand to heme centers.   Since the 
crystallization of a protein complex is greatly affected by its stability in solution, it was 
important to enhance the stability of such a Mb(NOAmph) product.  I thus turned to the 
sw MbH64A distal pocket single mutant, which has a greater ligand access to the heme 
pocket. Our lab had worked with sw MbH64A previously in another project (c/o Bing 
Wang).  I also substituted the 1-phenyl-2-nitropropane starting reagent with N-
hydroxyamphetamine to react with sw MbH64A in the reaction.   The distal pocket 
His64 residue in Mb is well known as a “gate” for ligand entry and escape.31 The 
substitution of histidine by alanine would thus likely open the gate and allow better 
ligand access to the active center.  Fortunately, we noted from UV-vis spectroscopic 
studies, that these changes increased the reaction rate and stability of the Mb(NOAmph) 
protein complex. 
Figure 3.10 shows the UV-vis spectral monitoring time course of the reaction 
between N-hydroxyamphetamine and sw metMbH64A ( λmax 406 nm).   I observed a 
gradual decrease of the Soret peak of sw metMbH64A over an 80 min reaction period, 
accompanied by the appearance of three new peaks at 425, 541 and 573 nm. These new 
peaks are consistent with those of other Mb(RNO) proteins,30 and are assigned to the sw 
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MbH64A(NOAmph) product.  It is also interesting to note that a small shoulder around 
402 nm started showing up during this reaction (even after ~30 mins).  In fact, the 
 
Figure 3.10. Time course of UV-vis spectra showing the conversion of ferric sw 
MbH64A (blue line;  λmax 406 nm) to sw MbH64A(NOAmph) during an 80 min 
reaction time period (orange line;  λmax 425 nm). Spectra were recorded at 0 s (blue), 1 
min (dark grey), 2 min (grey), 5 min (purple), 15 min (green), 30 min (yellow), 60 min 
(orange), and 80 min (red). [Mb] = 2.2 µM; 100 mM phosphate buffer, 1 mM EDTA, 
pH 7.4. 
	  
spectra taken before the 30 min time period had good isosbestic points at 417, 502, 524 
and 603 nm (not shown), which indicated a 1:1 reaction up to that point. These 
isosbestic points became less clear in subsequent spectra collected after this initial 30 
min time period. The formation of this unusual shoulder around 402 nm is probably the 
result of some unexpected side reactions of protein.  
This new complex sw MbH64A(NOAmph) showed a high stability in solution 
at room temperature (Figure 3.11). The green and red lines in Figure 3.11 represent the 
spectrum of the same protein solution after 1 day and 5 days of reaction time, 
respectively. Although we could still observe the shoulder peak at 402 nm, there was no 
sign of decomposition of the sw MbH64A(NOAmph) to the met form ( λmax 406 nm; 
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shown in black in the Figure) during this 5 day period.  The stability of this new 
complex allowed for its crystallization and X-ray structural characterization (see later). 
 
Figure 3.11.  The UV-vis spectum showing no decomposition of swMbH64A-NOamph 
after the solution was left in air for 5 days. The black line is the spectrum of the ferric 
swMbH64A. The green line and red line showing the spectra of the solution after 1 day 
and 5 days (100 mM phosphate buffer, 1 mM EDTA, pH 7.4). 
	  
The addition of sodium dithionite to the ferrous sw MbH64A(NOAmph) 
solution did not lead to any change of the spectrum.  However, addition of the oxidant 
potassium ferricyanide to the solution resulted in a quick spectrum change that indicated 
formation of the ferric met form.  As a result, the bound ligand in the heme pocket 
quickly dissociated from the metal as we have shown previously in heme model 
complexes (ferric porphyrins have low affinity for RNO ligands, as there is limited π 
backbonding available from the d5 ferric center to the π* orbital of the RNO ligand). 
3.3.3 Crystallographic results of the Hb(MeNO) and Hb(EtNO) products 
From the UV-vis spectral studies above, only MeNO2 and EtNO2 reacted with 
Hb in the presence of a reducing agent to form complexes that were sufficiently stable 
for crystallization. Both the oxyHb and metHb precursor proteins were used in the 
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reactions. The metHb reaction, after appropriate workup, produced suitable crystals, 
whereas those obtained from the oxyHb reaction were not as suitable for X-ray 
diffraction studies (Figure 3.12). 
             
Figure 3.12. Hb(EtNO) crystals grown from (left) the metHb/nitroethane/dithionite 
reaction, and (right) from the oxyHb/nitroethane/dithionite reaction.  
	  
Crystals of Hb(MeNO) were generated using the batch method, and the crystal 
structure was solved to 2.05 Å resolution.  Comparisons with known Hb crystal 
structures, including an analysis of the root mean square deviations between the 
tetramers as well as the critical contacts at the α1β2 interface, show the Hb(MeNO) 
crystal structure to be in the R state. The determination of the quaternary structures of 
the Hb(RNO) complexes will be discussed at the end of this section. 
 The electron density maps, and in particular the Fo–Fc omit electron density 
map of the active sites of the α and β subunits (Figure 3.13) clearly reveal the presence 
of V-shaped electron density in both subunits due to bound nitrosomethane (MeNO) 
ligands. The MeNO ligands bind Fe via their N atoms, and are further stabilized by H-
bonding between the nitroso O atoms with the distal His ligands.  The nitrosomethane 
CNO planes are generally situated between adjacent porphyrin N(pyrrole) atoms.  The 
heme propionates of the α heme are pointed in different directions; one pointed in the 
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general direction of the distal pocket, and the other in the direction of the proximal 
pocket.  In contrast, both heme propionates of the β heme point away from the distal 
His63 residue suggesting, perhaps, a higher likelihood of ligand access to/from this 
distal pocket.  Importantly, this was the first report of a metal-MeNO crystal structure 
for any protein. 
 
Figure 3.13. (Top) 2Fo–Fc electron density maps (grey mesh, contoured at 1.0 σ), and 
(Bottom) Fo–Fc omit electron density maps (green mesh, MeNO groups, contoured at 
3.0 σ) and final models of the α and β active sites of the Hb(MeNO) complex (PDB 
accession code 4M4A, 2.05 Å resolution).  
	  
We were also able to obtain crystals of Hb(EtNO) from the nitroethane reaction, 
and we solved the structure to 2.0 Å resolution. The 2Fo–Fc electron density maps and 
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Fo–Fc omit electron density maps for the product derived from the dithionite-reduced 
Hb/EtNO2 reaction are shown in Figure 3.14.  
 
Figure 3.14. (Top) 2Fo–Fc electron density maps (grey mesh, contoured at 1.0σ), and 
(Bottom) Fo–Fc omit electron density maps (green mesh, EtNO groups, contoured at 
3.0σ) and final models of the α and β active sites of the Hb(EtNO) complex (PDB 
accession code 4M4B, 2.0 Å resolution). 
	  
The 2Fo–Fc map of the α heme is consistent with the presence of the bound 
nitrosoethane (EtNO) ligand.  The C–C–N=O backbone of the EtNO ligand in the α 
subunit is best modeled in the trans form with a torsion angle of –144.2°, with the 
nitroso O atom H-bonded to the distal His58 residue and pointing in the direction of a 
porphyrin N atom, and the hydrophobic Et group pointing towards the interior of the 
 86 
subunit (Figure 3.15).   
There are substantial structural differences between the α and β distal pockets in 
this Hb(EtNO) derivative.  First, there is a notable lack of defined electron density for 
an ordered EtNO ligand in the β subunit of the structure (Figure 3.14).  In addition, we 
had difficulty in modeling a single β heme in the distal pocket in its expected position.  
Consequently, we relied on an anomalous map that revealed two Fe positions, labeled 
Fe1 and Fe2 in Figure 3.16, in a 1:1 ratio that were 4.9 Å apart in the final model.  The 
two Fe positions were used to model the core structures of the two hemes; we note that 
there was not enough observable electron density even in the 2Fo-Fc map to accurately 
model the β hemes to determine if any chemical modifications had occurred in the 
porphyrin macrocycle. 
 
Figure 3.15. Overlay of the heme active sites of the beta subunit of Hb(EtNO) (light 
grey) and that of Mb(EtNO) (black), showing the relative orientations of the EtNO 




Figure 3.16. The Fe anomalous map (contoured at 3.0σ) and the final model of the β 
heme site of the Hb(EtNO) structure (PDB accession code 4M4B, 2.0 Å resolution).  
The occupancies of Fe1 and Fe2 are modelled at 50% for each position. 
	  
Importantly, the position of Fe2 in Figure 3.16 places it in a position to interact 
weakly with the distal His63 residue (distance of 3.2 Å). This distal His63 imidazole 
ring experiences a twist of ~35° as it interacts weakly with the Fe2 center.  The proximal 
(His92)N–Fe1 distance of 2.9 Å in the β subunit (c.f., 2.3 Å in the α subunit) is also 
long, and combined with the ~0.8 Å movement of the imidazole NƐ atom towards the 
protein exterior, likely helps facilitate the departure of the heme from the β active site 
pocket.  
The observation of heme slippage by 4.9 Å in the β subunit of the Hb(EtNO) 
product is remarkable.  This lateral movement of the heme towards the protein exterior 
is similar to that (~4.8 Å) recently reported for an unusual Hb(ONO)d,p complex in 
which proximal ligand (nitrite) binding is present.32 In the Hb(EtNO) structure, the F-
helix in the β subunit remains ordered but with high B factor, suggesting its ability to 
unwind to allow the observed heme slippage.   
     It is likely the π-acidity of RNO plays a role in the degradation of the Hb(EtNO) 
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complex described here. Dithionite is known to cause degradation of dilute solutions of 
oxyHb.33,34 However, we note that although both Hb(MeNO) and Hb(EtNO) complexes 
were prepared similarly in the presence of dithionite, only the Hb(EtNO) showed the 
heme slippage; thus making it unlikely that dithionite was the primary factor 
responsible for this phenomenon. Insight into the difference in apparent stability of the 
Hb(MeNO) vs. Hb(EtNO) is provided by the observation that the axial Fe–N bonds in 
Hb(EtNO) are slightly longer than those in the Hb(MeNO) analog (Figures 3.13 and 
3.14), suggesting that the MeNO ligands are held tighter than EtNO to Fe in the crystal.  
This may help explain the observation of the heme degradation in Hb(EtNO) but not 
Hb(MeNO) under the conditions used. 
 We compared our human Hb(RNO) crystal structures with representative 
quaternary T, R, and R2 human Hb structures in terms of the root mean square 
deviation (rmsd) between the tetramers, as well as the critical contacts at the α1β2 
interface that help define the description of the quaternary state.  The rmsd between the 
different structures with least-square superposition of Cα of the tetramers (Table 3.2) 
suggest that the Hb(RNO) structures adopt the quaternary R conformation.  Consistent 
with these results, the α1β2 interfaces, also a measure of quaternary matrix, of the 
Hb(RNO) structures are similar to those of the R state structures but different from the 
R2 or T structures (Figure 3.17). 
 In typical R state structures, the α1β2 dimer interface residue β2His97 lies 
between residues α1Thr41 and α1Thr38, which is what was observed in our ordered 
Hb(MeNO), although it lacked the R state H-bond interaction between the carbonyl 
atom of β2His97 and the hydroxyl of α1Thr38 (Figure 3.17).  In the quaternary T state 
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structure, the α1β2 dimer interface rearranges, resulting in β2His97 jumping a turn to 
locate between α1Pro44 and α1Thr41, while in the R2 structure the rearrangement of 
the α1β2 has moved β2His97 significantly away from both α1Thr41 and α1Thr38, 
although it is still located between these two residues. 
 
Table 3.2. RMSD calculationsa 
 PDB i.d. description rmsd XYZ(Å) ref. 
Hb(EtNO) 4M4B (magenta) this work 0.364 - 
Hb(CO) 1AJ9 (red) R state 0.475 35 
deoxyHbb 1B86 (blue) T state 2.544 36 
Hb(CO) 1BBB (black) R2 state 1.681 37 
Hb(CO) 1YZI (cyan) R3 state 1.72 38 
a For this calculation, we fixed the Cα chains of the reference tetrameric Hb(MeNO) 
structure, and performed the rms deviations for Cα chains of the other tetrameric 









Figure 3.17.  The α1β2 interface of representative Hb structures.  (A) The α1β1 
subunits were superimposed using a T state deoxy Hb structure as the reference (PDB 
accession code: 1B86, 2.5 Å resolution; shown in blue). This generates the same 
positions of the α1 C helices, but clearly shows different positions of the β2 FG corners 
for different quaternary structures.  The R state Hb(CO) (PDB accession code: 1AJ9, 
2.2 Å resolution) is shown in red; the R2 state Hb(CO) (PDB accession code: 1BBB, 
1.7 Å resolution) is shown in black; and the R3 state Hb(CO) (PDB accession code: 
1YZI, 2.07 Å resolution) is shown in cyan; the Hb(MeNO) (PDB accession code: 
4M4A, 2.05 Å resolution; this work) is shown in green; the Hb(EtNO) (PDB accession 
code: 4M4B, 2.0 Å resolution; this work) is shown in magenta. (B) Highlights of key 
residues (α1Thr38, α1Thr41 and β2His97) at this α1β2 interface.  This analysis shows 
that the Hb(RNO) structures are in the R state. 
	  
3.3.4 Crystallographic results of the sw MbH64A(NOAmph) complex 
Crystals of the product from the (ferric) sw MbH64A with AmphNHOH ( λmax 
426 nm; Figure 3.10) were generated by soaking pre-formed crystals of ferric sw 
MbH64A (kindly provided by Bing Wang of our lab) with the AmphNHOH reagent. 
We preferred this "crystal soaking method" over co-crystallization in this work since the 
soaking method usually retains the same space group and unit cell of the crystal which 
served the purpose of comparing the structures of the precursor ferric sw MbH64A and 
its ferrous sw MbH64A-NOAmph product.  We tried two different methods to 
introduce the AmphNHOH reagent into the protein active site.   The first method 
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involved the direct addition of solid AmphNHOH into the mother liquor containing the 
sw MbH64A crystals, and the other method involved the addition of a solution of 
AmphNHOH dissolved in methanol. When solid AmphNHOH was carefully added into 
the solution containing the crystals, we observed the slow dissolution of the white 
AmphNHOH powder over 2-3 hours, along with a color change of the dark red crystals 
of sw MbH64A to a bright pink color. From our experience, this type of color change 
indicates the reduction of ferric heme to the ferrous form.  Although this color change 
occurred using both approaches, only the crystals from the addition of solid 
AmphNHOH gave good quality X-ray diffraction data.  
The crystal structure of sw MbH64A(NOAmph) was solved to 1.73 Å 
resolution.  The Fo–Fc omit electron density map clearly shows the presence of a bulky 
ligand in the active center (Figure 3.18).  Fortunately, I had already obtained the 
structure of (OEP)Fe(NOAmph)(1-MeIm) shown in Chapter 2, so the .cif file of the 






Figure 3.18. (left) 2Fo–Fc electron density maps (purple mesh, contoured at 1.0 σ), and 
(right) Fo–Fc omit electron density maps (green mesh, NOAmph groups, contoured at 
3.0 σ) and final models of the active site of the sw MbH64A(NOAmph) complex. 
	  
The NOAmph ligand binds to the Fe center via the N atom, similar to that 
observed in the other ferrous Hb(RNO) compounds discussed in the previous section.  
In the high resolution X-ray crystal structures of the heme model-NOAmph complexes 
discussed in Chapter 2, the Fe-N(NO) distances are in the 1.80-to-1.95 Å range, and are  
generally shorter than the Fe-N(axial trans ligand) distances (2.0-2.1 Å). The bond 
lengths in sw MbH64A(NOAmph) are very close to those observed in model 
complexes.  In sw MbH64A(NOAmph), the Fe-N(NO) distance is 1.9 Å and the Fe-
N(His) distance is 2.1 Å.  Another feature that is consistent with the model complex is 
the orientation of the CNO plane of the NOAmph ligand that bisects adjacent porphyrin 
N atoms in both the model heme system complex and in sw MbH64A(NOAmph). 
Furthermore, the mutually trans CNO and 1-MeIm planes in sw MbH64A(NOAmph) 
are more eclipsed than staggered, a feature also observed in the model complexes in 
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Chapter 2. These structural similarities between the protein and model complexes are 
probably due the fact that the only significant interaction between the ligand and the 
heme is via the Fe-N bond.  Indeed, no H-bonding interaction between ligand and distal 
pocket residues in the heme pocket of swMbH64A was observed.  This lack of a H-
bonding interaction between the ligand and the distal pocket is unusual, but not 
unexpected since the His64 residue was mutated to alanine (other distal pocket H-
bonding residues include Thr67 and Y107).  In contrast, H-bonding interactions 
between the nitroso O atoms with the distal His residues were observed in the Hb(RNO) 
derivatives (see earlier) and other wt Mb(RNO) complexes.16 A notable exception was 
for the legHb(PhNO) crystal structure, where the large distal pocket did not favor direct 
H-bonding of the PhNO ligand with any distal pocket residue. 17 Figure 3.19 (left) 
shows an example of the H-bonding with distal His in the heme pocket of hhMb(EtNO). 
This H-bond helped stabilize the bound ligand and likely determines the orientation of 
the ligand.  In the absence of this distal His residue (i.e., in the H64A mutant), this H-
bonding is not present in the structure of sw MbH64A(NOAmph) (Figure 3.19) (right). 
 
 
Figure 3.19.  (Left) The H-bonding interaction between the nitroso O atom with the 
distal His in the heme site of hh Mb(EtNO).  (Right) Lack of a H-bonding interaction 
stabilization of the NOAmph ligand in the heme site of sw MbH64A(NOAmph). 
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An unusual feature in the structure of sw MbH64A(NOAmph) is the orientation 
of the ligand in the heme pocket.  In all the wt Hb(RNO) and Mb(RNO) crystal 
structures, the nitroso (N=O) moiety points outward towards solvent and is stabilized 
via H-bonding with the distal His residue, and the alkyl/aryl organic fragment pointes 
inwards towards the hydrophobic interior of the protein. In sw MbH64A(NOAmph) 
(Figure 3.19), the ligand is oriented with the nitroso moiety pointing inwards, and the 
hydrophobic/organic fragment pointing towards the polar solvent exterior. This ligand 
orientation was unexpected, as it is generally believed to be energetically unfavorable 
based on polarity arguments.  Why is the ligand orientated in such an unusual way? 
One likely explanation is the steric effect of the ligand that would prevent the bulky Ph 
group to be accommodated in the distal pocket hydrophobic interior.  To examine this 
further, we took the sw MbH46A(NOAmph) final model from the X-ray structure, and 
artificially rotated the NOAmph ligand in such a way to position it in the "normal 
expected" orientation with the bulky organic fragment in the distal pocket interior. We 
noted, surprisingly, that there were no significant steric clashes with any of the distal 
pocket residues.  Clearly, more work needs to be done in this area to determine the 
factors that control ligand orientation in Mb complexes. 
To better understand how the NOAmph ligand interacted with the active site of 
sw MbH64A, we compared the structures of sw MbH64A(NOAmph) with its precursor, 
ferric swMbH64A(H2O) (Figure 3.20, provided by Bing Wang) in the same space group.  
Upon binding NOAmph in the ferrous form, the structure displayed conformational 
changes including the movement of the protein Cα atoms by as much as 1.5 Å. The 
rmsds (root mean square deviations) for these two structures are 0.27 Å for the 153 
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main-chain Cα atoms, and 0.67 Å for all atoms.  In Figure 3.20 (top), it is observed that 
the CD loop of sw MbH64A(NOAmph) moved towards the solvent region, leaving a 
larger space for ligand access.  Additional conformational changes were observed for 
the side-chains near or around the heme pocket.  Figure 3.20 (bottom) shows the overlay 
of the heme sites in these two structures.  Overall, the distal residues above the heme 
macrocycle moved upward, and the proximal residues below the heme moved slightly 
downward from their original positions. These changes were not unexpected, as the 
movements would enlarge the size of heme pocket allowing room for the ligand.  
Among these distal pocket residue movements, Val68 and Phe43 had the most 
significant displacements. Val68 is usually considered a kinetic barrier for ligand 
binding in Mb.39 In our structure, the isopropyl group of Val68 was “pushed away" 
from the nitroso moiety of NOAmph, with a clockwise rotation of 109° to avoid a steric 
clash with the nitroso O-atom.  The Phe43 residue displayed a displacement of 1.2 Å 













                         
Figure 3.20. (Top) Overlay of the tertiary structures of sw MbH64A(NOAmph) 
(magenta) and ferric sw MbH64A(H2O) (blue) showing the movement of the CD loop 
of the protein upon the ligand binding.  (Bottom) Overlay of the heme sites in sw 
MbH64A(NOAmph) (green) and ferric sw MbH64A(H2O) (blue) shown from the 




Figure 3.21. Overlay of the heme sites of sw MbH64A(H2O) (blue) and sw 
MbH64A(NOAmph) (green) showing the disruption of the salt bridge between Arg45 
and the heme propionate, with the formation of H-bonding between Arg45 and Asp60. 
The Arg45 in sw MbH64A(NOAmph) (green) flips towards Asp60.  
	  
We also noted, from the overlay of these two structures, the breaking of the salt 
bridge between Arg45 (positively charged) and a heme propionate side chain 
(negatively charge) upon binding of the NOAmph ligand with concomitant Fe 
reduction.  The interaction between Arg45 and the heme propionate is known for its 
function of regulating ligand binding and stabilizing heme center in Mb.40 Figure 3.21 
shows the significant movement of Arg45 towards the C helix upon ligand binding. The 
heme propionate side chain in question also moved downwards slightly with the 
observation of a more flat heme macrocycle.  These changes likely disrupted the H-
bonding between Nω(Arg)-O(propionate) and NƐ(Arg)-O(priopionate).  This disruption 
of the Arg-propionate salt bridge probably allowed for a more open access entry for the 
bulky NOAmph ligand into the pocket and binding to the Fe center.  Interestingly, the 
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flip of Arg45 also led to the formation of a new salt bridge with the carboxylate oxygen 
of Asp60 shown in Figure 3.21.  
We also compared the structure of sw MbH64A(NOAmph) with another Mb 
complex in the P6 space group containing a bulky ligand, namely  sw 
MbH64A(CNC4H7) whose structure was reported by Smith et al. (pdb access code 
103M).41 In the reported structure, the hydrophobic alkyl chain of n-butyl isocyanide 
displayed the same outward-pointing orientation as the sw MbH64A(NOAmph) 
described in this work. However, there are some significant differences between these 
two structures.  
The superposition of the tertiary and heme site structures of sw 
MbH64A(CNC4H7) and sw MbH64A(NOAmph) are shown in Figure 3.22. The Cα 
backbones of these two structures superimpose well.  In both structures, the 
hydrophobic portions of the ligands were pointing outwards towards the solvent region. 
The Ph group of NOAmph and the butyl group of CNC4H7 bend towards the heme 
planes with a (N)C-C-C(Ph) angle of 120° (for NOAmph) and an N-C-C angle of 109° 
(for CNC4H7).  
One important difference is the distance between Arg45 and heme propionate 
side chains in these two structures. As discussed above, the addition of NOAmph as a 
ligand in sw MbH64A(NOAmph) disrupted the Arg45-propionate salt bridge to likely 
assist in ligand access and binding. In contrast, in sw MbH64A(CNC4H7), the Nω(Arg)-






Figure 3.22. (Top) Overlay of the tertiary structures of sw H64AMb(CNC4H7) (orange; 
PDB accession code: 103M, 2.0 Å resolution) and sw MbH64A(NOAmph) (green).  
(Bottom) Overlay of the heme sites in sw MbH64A(CNC4H7) (magenta) and sw 
MbH64A(NOAmph) (green) shown from the propionate side of the heme. The n-butyl 
isocyanide and NOAmph ligands show similar outward-pointing orientations. In the 
structure of sw MbH64A(CNC4H7), the ligand N-atom H-bonds to Val68.  
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Also, it is evident from Figure 3.22 that the Val68 of sw MbH64A(CNC4H7) did 
not alter its original position after ligand binding.  Instead of rotating away from the 
ligand as seen for sw MbH64A(NOAmph), the Val68 is within a H-bond interaction 
(distance of 2.9 Å) with the CNC4H7 ligand.   
In this work, we first studied the reactions between Hb and a series of simple 
RNO (R = Me, Et, Pr, iPr) compounds by UV-vis spectroscopy, and reported the first 
crystal structures of RNO derivatives of human Hb, which reveal structural distortions 
that will lead to the biologically relevant heme loss process. 
The ability of Mb to bind with NOAmph was also examined using both UV-vis 
spectroscopy and X-ray crystallography. The results indicated that despite the relatively 
small active site of myoglobin, it could still react with NOAmph and form a FeII-
NOAmph protein complex. In addition, the crystal structure of sw MbH64A(NOAmph) 
was successfully obtained, which represents the first crystal structure of any heme 
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Chapter 4. Interactions between nitric oxide and formally d6 
metalloporphyrins of cobalt and rhodium 
4.1 Introduction 
As mentioned in Chapter 1, NO is a biological signaling molecule that interacts 
with heme proteins.1,2 Iron is the metal center of heme proteins. Not surprisingly, most 
of the previous research on the interactions between NO and heme models has involved 
Fe and other group 8 metals as the central metal of the metalloporphyrins.3-7 Cobalt also 
plays an important role in biology in the form of cobalamin,8,9 and CoIII is isoelectronic 
with FeII. Surprisingly, the study on the interactions between NO and cobalt porphyrins 
has been very limited to date.  To the best of our knowledge, only five-coordinated 
nitrosyl cobalt porphyrin complexes of the form (por)Co(NO) have been structurally 
characterized and reported.10 The study on the interactions of NO and porphyrins 
containing other group 9 metals, such as rhodium and iridium, is even more rare. In 
fact, there is only one literature report on the preparation and EPR studies of the nitrosyl 
rhodium porphyrin ((TPP)RhNO), which dates back 35 years.11 
The lack of knowledge in this area was surprising to us. Could it be that the 
bonds between NO and the metal centers of Co/Rh porphyrins may not be as strong as 
those of the group 8 metal porphyrins, thus making their complexes difficult to obtain? 
Our goal in this chapter is to gain an understanding of this “unknown” area.  
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4.2 Experimental section 
4.2.1 Materials, instrumentation, and methods 
The reactions were performed under anaerobic conditions using standard 
Schlenk techniques under an atmosphere of nitrogen and/or in an Innovative Technology 
Labmaster 100 Dry Box unless stated otherwise. Solvents used for the reactions were 
obtained from an Innovative Technology Pure Solv 400-5-MD Solvent Purification 
system under an atmosphere of nitrogen. The Tensor 27 FTIR spectrometer equipped 
with a mid-IR fiber-optic dip probe and liquid nitrogen cooled MCT detector (RemSpec 
Corporation, Sturbridge, MA, USA) was used to record the infrared spectra of solution 
samples. Proton NMR spectra were recorded on a Varian Mercury VX 300 MHz 
spectrometer at room temperature, and the signals were referenced to the solvent 
employed (CDCl3 at 7.24 ppm). UV-vis data were collected on an HP 8453 diode array 
instrument. X-ray diffraction data were collected by Dr. Douglas R.Powell using a 
diffractometer with a Bruker APEX ccd area detector12,13 and graphite-monochromated 
Mo Kα radiation (λ = 0.71703Å).  
Hydrochloric acid (37%) was purchased from EMD chemicals; cobalt(II) meso-
tetraphenylporphine was purchased from Strem; benzonitrile (99%), tetrabutyltin (93%), 
methanol (99.8%), methanol (anhydrous, 99.8%) and anhydrous ethanol were purchased 
from Aldrich; dichloromethane, acetonitrile, benzene and hexane were collected from the 
solvent distillation system under nitrogen; chloroform was purchased from Fisher; silica 
gel (Mesh 60-200) was purchased from Baker; anhydrous sodium acetate, di-µ-
chlorotetraethylene dirhodium (I) and rhodium (III) chloride hydrate were purchased 
from Aldrich; chloroform-d (99.8%) was purchased from Cambridge Isotope 
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Laboratories. Nitric oxide (98%, Matheson Gas) was purified by passing the gas through 
a column of KOH pellets followed by a cold trap (acetone/dry ice, -78oC) to eliminate 
higher nitrogen oxides. TPPH2 (TPP = 5, 10, 15, 20-tetraphenylporphyrinato dianion) 
was prepared following literature methods.14 
(TPP)CoCl was prepared by a literature method15 and crystallized from 
CH2Cl2/hexane.  
4.2.2 Synthesis  
(TPP)Co(n-Bu)(1) : The compound (TPP)Co(n-Bu) was prepared following published 
method.16 Tetrabutyltin (Sn(n-Bu)4, 18 mg, 0.05 mmol) was added to a 
chloroform/acetonitrile (5:1) solution of (TPP)CoCl (36 mg, 0.05 mmol) in a Schlenk 
tube. The Schlenk tube was kept in the dark by wrapping it tightly with aluminum foil. 
After stirring for 3 hours, the solution turned to a red color. It was then taken to dryness 
in vacuo and the residue was washed with hexane. The slow evaporation of a 
CH2Cl2/hexane (1:1) solution of the residue in a glove box resulted in the formation of 
block shaped red/black crystals of (TPP)Co(n-Bu). The isolated yield of the crystals is 
98%. 1H NMR (CDCl3, ppm): 8.75 (s, 8H, pyrrole-H of TPP), 8.10 (m, 8H, o-H of TPP), 
7.72 (m, 12H, p/m-H of TPP), -0.71 (t, 3H of Bu), -1.33 (m, 2H of Bu), -4.63 (m, 2H of 
Bu), -3.65 (t, 2H of Bu),. UV-vis (CH2Cl2,  λ/nm): 408, 531. IR (KBr, cm-1): 1697 s, 
1653 m, 1598 s, 1559 w, 1540 m, 1457 s, 1440 s, 1375 m, 1351 s, 1174 m, 1156 w, 1111 
w, 1072 s, 998 s, 798 s, 752 s, 718 w, 701 s.  
Attempted preparation of (TPP)Co(NO)(n-Bu)(2): Crystals of (TPP)Co(n-Bu) were 
carefully selected and placed in a small glass vial. The vial and its contents were sealed 
with an air-tight septum and electrical tape. It was purged with nitrogen through a needle 
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for 2 hours to remove the oxygen inside the vial. NO gas was then introduced into the 
vial through a needle for 20 mins to ensure that the glass vial was filled with NO, and the 
vial contents were kept under NO for more than one week. An X-ray crystal structural 
determination of the product did not indicate the binding of NO to the metal center of 
(TPP)Co(n-Bu). However, we observed the formation of a new peak in the IR-spectrum, 
which was assigned to (TPP)Co(NO). IR (KBr, cm-1): υNO =1682 s m; also 1696 m, 1634 
s, 1600 w, 1557 w, 1540 w, 1462 s, 1384 m, 1351 s, 1175 w, 1074 s, 1004 s, 799 s, 753 s, 
701 s, 667 m.  
(TPP)Rh(Ph)(3): The compound of (TPP)Rh(Ph) was prepared following a published 
method with slight modification.17 To a 5 mL CH2Cl2 solution of Rh2(CO)4Cl2 (125 mg, 
0.06 mmol) in a Schlenk tube was added TPPH2 (25 mg, 0.04 mmol) and anhydrous 
NaOAc (125 mg, 1.5 mmol). The solution was stirred for an hour under a flow of 
nitrogen until the solvent completely evaporated. This procedure was repeated with the 
addition of another 5 mL CH2Cl2 into the Schlenk tube. The black red residue was 
dissolved in CH2Cl2 and filter-cannulated to another Schlenk tube under nitrogen. After 
taking the contents to dryness in vacuo, 30 mL of benzene was added to dissolve the 
solid and the mixture was heated to 80 °C for 8 hours in the dark in the presence of 
trace air. The air was introduced by connecting the Schelnk tube to air through a needle 
placed on the septum. A black precipitate formed on the bottom of Schlenk tube during 
the reaction. After cooling the reaction vessel down to room temperature, the solution 
was filtered and concentrated to 2 mL before loading on a silica column (1 x 15 cm) 
that was prepared in benzene/hexane (2:1). The product was then eluted using a 
concentration gradient of increasing benzene (from 65% to 75%). The second visible 
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fraction of the eluent was collected and identified as (TPP)Rh(Ph) by UV-vis 
spectroscopy. This fraction was taken to dryness in vacuo and the product obtained in 
45% yield. The slow evaporation of a CH2Cl2/hexane (1:1) solution of the product in a 
glove box resulted in the formation of red block-shaped crystals in 3 days. UV-vis 
(CH2Cl2,  λ/nm): 412, 520.  1H NMR (CDCl3, ppm): 8.68 (s, 8H, pyrrole-H of TPP), 
8.09 (d, 8H, o-H of TPP), 7.67 (m, 12H, p/m-H of TPP), 5.19 (t, 1H, p-H of C6H5), 4.70 
(t, 2H, m-H of C6H5), 0.21 (d, 2H, o-H of C6H5). IR (KBr, cm-1): 1633 m, 1595 m, 1560 
w, 1537 w, 1488 w, 1470 s, 1442 s, 1351 s, 1306 m, 1261 w, 1027 w, 1175 w, 1073 s, 
1011 s, 796 s, 756 s, 703 s, 656 w. 
(TPP)Rh(Ph)(CH3OH): A slow evaporation of a solution of (TPP)Rh(Ph) in 
CH2Cl2/methanol in a glove box over 3 days resulted in the formation of orange plate-
shaped crystals, which was determined, by X-ray crystallography, to be 
(TPP)Rh(Ph)(CH3OH).  
(TPP)Rh(NO)(Ph): Crystals of (TPP)Rh(Ph)(CH3OH) were carefully picked and placed 
in a small glass vial. The vial and its contents were sealed with an air-tight septum and 
secured by electrical tape. It was purged with nitrogen through a needle for 2 hours to 
remove the trapped air. NO gas was then introduced into the vial through a needle for 
20 mins to ensure the glass vial was filled with NO, and the vial contents kept under NO 
for more than one week. The crystals were then harvested under argon. IR (KBr, cm-1): 
υNO = 1811 w; also 1596 s, 1561 s, 1535 m, 1470 m, 1440 s, 1397 w, 1351 s, 1321 m, 
1308 s, 1260 w, 1207 m, 1176 s, 1073 s, 1010 s, 796 s, 752 s, 700 s, 657 m.  
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A similar experiment was also performed with the five-coordinate (TPP)Rh(Ph) 
crystals. No formation of nitrosyl complex was observed for the later complex using X-
ray crystallography. 
(TPP)RhCl: (TPP)RhCl was prepared by a published method.18 To a 10 mL PhCN 
solution of RhCl3⋅H2O (0.104 g, 0.50 mmol) was added H2TPP (0.157 mg, 0.51 mmol). 
The mixture was refluxed in air for 3 hours, during which time the color of the solution 
changed from purple to red. The mixture was taken to dryness in vacuo and re-dissolved 
in a small amount of CH2Cl2 to load onto a silica column (1 x 15 cm) prepared in 
CH2Cl2. The column was washed with a gradient elution of CH2Cl2/PhCN. Three 
fractions were eluted and were examined by UV-vis spectroscopy. The second fraction, 
which was identified as the known (TPP)RhCl, was collected. The eluent was dried in 
vacuo and the red residue was re-dissolved in a mixture of methanol and CH2Cl2. A 
slow evaporation of this solution in a dry box gave a mixture of purple block-shaped 
crystals and red plate-shaped crystals. The isolated yield of the crystals is ~70%. Both 
of the crystals were examined by X-ray crystallography. Only the block-shape crystals 
gave good X-ray diffraction data, and the compound was determined to be the expected 
product (TPP)RhCl(CH3OH). UV-vis of (TPP)RhCl (CH2Cl2,  λ /nm): 422, 533, 568. 
IR (KBr, cm-1): 1652 w, 1635 w, 1595 s, 1538 m, 1488 w, 1439 s, 1352 s, 1310 s, 1207 
m, 1176 s, 1072 s, 1012 s, 795 s, 754 s, 703 s, 666 w.  
Preparation of (TPP)Rh(NO)Cl: The preparation of (TPP)Rh(NO)Cl followed the same 
procedure described for Rh(TPP)(NO)(Ph). Crystals of (TPP)RhCl were exposed to NO 
at room temperature for two weeks in an anaerobic environment. A product crystal was 
harvested under argon for an X-ray diffraction study. IR (KBr, cm-1): υNO = 1732 w; 
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also 1633 w, 1594 m, 1538 s, 1439 s, 1397 w, 1352 s, 1309 m, 1261 s, 1206 m, 1175 s, 
1071 s, 1012 s, 795 s, 754 s, 703 s. 
(OEP)Rh(CH2Cl): This chemical was purchased commercially as “(OEP)RhCl” from 
Frontier Science.  The “(OEP)RhCl” we received was shown by UV-vis and 1H NMR 
spectroscopy to be a different chemical from what we initially expected. A slow 
evaporation of a CH2Cl2/hexane/methanol (7:1:1) solution of this chemical in a glove 
box resulted in the formation of crystals with a tree-like architecture in 3 days. The 
crystals were carefully selected and cut under a microscope. It was identified by X-ray 
crystallography as (OEP)Rh(CH2Cl). 1H NMR (CDCl3, ppm): 10.11 (s, 4H, meso-H of 
OEP), 4.05 (m, 16H, CH2CH3 of OEP), 1.90 (t, 24H, CH2CH3 of OEP), -3.31 (d, 2H, 
CH2Cl). UV-vis (CH2Cl2,  λ /nm): 394, 511, 543. IR (KBr, cm-1): 1652 w, 1549 m, 1464 
s, 1449 s, 1381 s, 1318 w, 1271 s, 1228 m, 1153 s, 1110 m, 1055 s, 1020 s, 995 s, 962 s, 
845 s, 747 m. 
Attempted preparation of (OEP)Rh(NO)(CH2Cl ): The attempted preparation of 
(TPP)Rh(NO)Cl followed the same procedure described for (TPP)Rh(NO)(Ph) using a 
gas-solid method. However, the X-ray diffraction data collected on the crystals were not 
of sufficient quality for structure determination.  
(TPP)Rh(C6H4Cl): This chemical was commercially purchased as “ (TPP)Rh” from 
Frontier Science. The “(TPP)Rh” we received was shown by UV-vis and 1H NMR 
spectroscopy to be a different chemical from what we initially expected. A slow 
evaporation of a CH2Cl2/methanol (4:1) solution of this compound in glove box resulted 
in the formation of plate-shaped crystals which were determined by X-ray 
crystallography to be a mixture of (TPP)Rh(p-C6H4Cl) and (TPP)Rh(m-C6H4Cl) (9:1). 
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1H NMR (CDCl3, ppm) of (TPP)Rh(p-C6H4Cl): 8.75 (s, 8H, pyrrole-H of TPP), 8.12 (m, 
8H, o-H of TPP), 7.72 (m, 12H, p, m-H of TPP), 4.76 (d, 2H, m-H of C6H4Cl), 0.17 (d, 
2H, o-H of C6H4Cl). UV-vis (CH2Cl2,  λ / nm): 413, 521, 634. IR (KBr, cm-1): 1649 s, 
1635 s, 1557 m, 1539 m, 1467 m, 1441 m, 1384 s, 1352 s, 1308 m, 1258 w, 1177 w, 
1076 s, 1047 w, 1010 vs, 839 w, 796 s, 753 s, 702 s.   
(TPP)Rh(NOC6H4Cl): The preparation of (TPP)Rh(NOC6H4Cl) followed the same 
procedure described for Rh(TPP)(NO)(Ph). Crystals of (TPP)Rh(C6H4Cl) were exposed 
to NO at room temperature for two weeks in an anaerobic environment, during which 
time the crystals turned to a darker color. The crystal was harvested under argon for an 
X-ray diffraction study. IR (KBr, cm-1): υNO = 1414; also 1632 s, 1574 w, 1556 w, 1538 
w, 1462 w, 1348 s,  1265 m, 1083 s, 1012 w, 866 s, 802 w, 736 w.  
((NO2)2TPP)Rh(Ph): NO gas was introduced into a 3 mL CH2Cl2 solution of 
Rh(TPP)Ph (3 mg, 0.003 mmol) in a Schlenk tube through a needle over a 25 min 
period. The solution changed from bright orange to a dark red color. The excess NO 
was then flushed away by N2, and ~2 mL hexane was added into the Schlenk tube. A 
slow evaporation of this solution in a glove box resulted in the formation of violet 
block-shaped crystals over a period of three days. The crystals were harvested in air for 
an X-ray diffraction study.  IR (KBr, cm-1): 1632 m, 1538 s, 1469 m, 1454 m, 1443 m, 
1346 m, 1261 s, 1175 w, 1158 w, 1097 m, 1074 m, 1032 m, 1031 m, 798 s, 754 w, 701 
m, 639 w. 
4.2.3 Infrared spectral monitoring of the reactions of the (por)Rh(R) compounds 
with NO 
The following is representative: Approximately 3 mg of a powered sample of 
the (por)Rh(R) was placed into a Schlenk tube equipped with an air-tight septum. The 
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tube was placed under vacuum for 30 mins and re-filled with nitrogen. CH2Cl2 (3 mL) 
was carefully added into the schlenk tube via an air-tight syringe to completely dissolve 
the reagent. NO gas was introduced into the solution using a gas-tight syring needle 
over a 25 min period. The solution was transferred to a glass vial protected by a blanket 
of nitrogen using an air-tight syringe to record its IR spectrum. 
For the spectral recording, a mid-IR fiber-optic dip probe was placed inside a 
small glass vial that was sealed in a clear ziplock bag. The ziplock bag was pre-purged 
with nitrogen for 1.5 hrs to remove any air. A blanket of N2 was maintained in and over 
the glass vial throughout the experiment. A background spectrum was taken with the 
N2. The product solution was transferred into the glass vial through an air-tight syringe 
under the protection of N2.  
4.3 Results and discussion 
4.3.1 Synthesis and characterization  
In this chapter, I describe the preparations and structural characterizations of a 
series of cobalt(III) and rhodium(III) porphyrins, including (TPP)RhCl, (TPP)Co(n-Bu), 
(TPP)Rh(Ph), (TPP)Rh(C6H4Cl) and (OEP)Rh(CH2Cl). Although the preparations of 
these precursor compounds have been reported by others previously, their crystal 
structures reported here were previously unknown. Importantly, these compounds were 
used by me as precursors for the reactions with NO gas to generate a previously 
unreported class of group 9 (por)Rh(NO)X derivatives. 
The known (TPP)RhCl complex was prepared by treating H2(TPP) with 
RhCl3•H2O in a solution of PhCN (eq. 4.1).18  It was isolated in 70% yield after 
purification by column chromatography. Interestingly, both red needle-like and purple 
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block-shaped crystals grew simultaneously from a solution of the product in 
CH2Cl2/MeOH. While these two types of crystals are different in shape and color, both 
of them were identified by UV-vis spectroscopy to be (TPP)RhCl (Table 4.1). 
Unfortunately, only the purple block-shaped crystals were of sufficient quality for X-ray 
diffraction data collection.  
 
                  
                                                 (4.1) 
 
The crystal structure of (TPP)RhCl with a coordinated methanol in the axial 
position is shown in Figure 4.1. The Rh-Cl bond length is 2.305 (19) Å.  The axial Cl 
atom displays a weak electrostatic interaction with a MeOH solvate molecule. A 3.45 Å  
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Figure 4.1. (Top) Molecular structure of (TPP)RhCl(MeOH). Hydrogen atoms have 
been omitted for clarity. (Middle) Perpendicular atom displacements (in units of 0.01 Å) 
of the porphyrin core atoms from the 24-atom mean porphyrin plane. (Bottom) The 
relative orientation of (TPP)RhCl(MeOH) and a neighboring MeOH and porphyrin.  
	  
distance between this Cl atom and a porphyrin phenyl group is outside of the range for a 
normal hydrogen bond. 
The alkyl and aryl σ-bonded d6 group 9 metal (Co, Rh) porphyrins employed in 
this chapter were prepared by previously reported methods.16,17 The first method 
involves the reaction of a main-group alkylating reagent with halogencobalt 
(III)/halogenrhodium (III) porphyrins (eq 4.2). A second method involves the oxidative 
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addition of cobalt (I)/rhodium (I) porphyrins with corresponding alkyl/aryl group (eq. 
4.3; see later).  
The preparation of  (TPP)Co(n-Bu) complex followed the first preparative 
method. (TPP)CoCl readily reacts with a mild alkylating reagent, tetrabutyltin, to form 




      
Organocobalt porphyrins are generally light sensitive,19 thus, the preparation and 
subsequent crystallization of (TPP)Co(n-Bu) were carried out in the dark. It is not 
surprising that when a CH2Cl2 solution of (TPP)Co(n-Bu) was studied by UV-vis 
spectroscopy under normal laboratory lighting, I observed a slow conversion of 
(TPP)Co(n-Bu) ( λmax = 409 nm) to an unidentified (TPP)CoIII complex ( λmax = 438 nm) 
(Figure 4.2). Fortunately, crystals of (TPP)Co(n-Bu) were stable in air in the dark for 
several weeks, as determined by UV-vis spectroscopy.  
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Figure 4.2. UV-vis spectra of the decomposition of (TPP)Co(n-Bu) in air. Solid line: 
spectrum of (TPP)Co(n-Bu) in CH2Cl2. Dashed line: after ~3 hrs in air under normal 
room lighting.  
	  
Crystals of the five-coordinate (TPP)Co(n-Bu) formed from a solution of 
CH2Cl2/hexane, and the structure was solved by X-ray crystallography (Figure 4.3). The 
X-ray structure of (TPP)Co(n-Bu) was unknown prior to my work in this area. The 
crystal structure displayed a Co-C distance of 2.018(3) Å, which is slightly longer than 
the corresponding Co-C bond (1.988 (2) Å) in (OEP)Co(Et).20 The elongation of Co-C 
bond with increased bulky alky group was also observed in six-coordinate cobaloxime 
complexes.21 The Cβ-Cγ distance is 1.512(4) Å while the Cα-Cβ distance of the butyl 
group in this structure is 1.480(4) Å, which indicates an increase of s character of the 
CH2 orbital. The short Cα-Cβ distance, along with a Co-Hβ-Cβ angle of 74.4
o, is 
indicative of an agnostic interaction between Hβ-Cβ-Co. Furthermore, an interporphyrin 
distance of 3.81 Å was observed between the adjacent 24-atom porphyrin planes.  
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Figure 4.3. (Top) Molecular structure of (TPP)Co(n-Bu). Hydrogen atoms have been 
omitted for clarity. (Bottom) A distance of 3.81 Å was observed between adjacent 24-
atom porphyrin planes. 
	  
The (TPP)Rh(Ph) complex was prepared by a reagent-induced oxidative 
addition of Rh2(CO4)TPP. The Rh(I) porphyrin (Rh2(CO4)TPP) undergoes an oxidative 
addition at 80 oC in benzene, and in the presence of trace air (O2), to form a d6 
(TPP)Rh(III)Ph complex (eq. 4.3, right). Work-up of the product resulted in its isolation 
in ~45% yield. The crystals of five-coordinate (TPP)Rh(Ph) and six-coordinate 
(TPP)Rh(Ph)(MeOH) complexes were obtained from the slow evaporation of a solution 
of CH2Cl2/hexane or CH2Cl2/methanol, respectively.  
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(4.3) 
 There are two unique molecules in the unit cell of the six-coordinate 
(TPP)Rh(Ph)(MeOH) structure. Figure 4.4 (top) shows the structure of molecule A. The 
Rh-C distances are 1.926(15) and 1.916(11) Å for molecules A and B, respectively.  
                         
                                            
Figure 4.4. (Top) Molecular structure of (TPP)Rh(Ph)(MeOH) (molecule A). Hydrogen 
atoms have been omitted for clarity except those on MeOH. (Bottom) Perpendicular 
atom displacements (in units of 0.01 Å) of the porphyrin core atoms from the 24-atom 
mean porphyrin plane. 
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We also obtained crystals of the five-coordinate (TPP)Rh(Ph) (Figure 4.5, top). 
The Rh-C bond lengths are 2.000(5) and 1.993(5) Å, which are about 0.05 Å longer 
than in the six-coordinate molecule with axial methanol. In this structure, there are two 
close contacts between porphyrin N atoms and the phenyl groups of an adjacent 
molecule (Figure 4.5, bottom).  
            
           
Figure 4.5. (Top) Molecular structure of (TPP)Rh(Ph). Hydrogen atoms have been 
omitted for clarity. (Bottom) A depiction of the close contacts between adjacent 
molecules.  
	  
The presence of air (O2), which was introduced into the benzene solution of 
Rh2(CO)4TPP through a needle on the septum of the schlenk tube, is crucial for the 
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synthesis of (TPP)Rh(Ph). In one of our experiments, when the benzene solution was 
completely anaerobic, the reaction resulted in a mixture of unreacted Rh2(CO)4TPP and 
the (TPP)Rh(Ph) complex, evidenced by the starting material’s vC=O (2056, 1995 cm-1)17 
in the IR spectrum after chromatography in air. Subsequent crystallization of this 
product mixture from a solution of CH2Cl2/methanol in a glove box generated crystals 
containing two different complexes, namely (TPP)Rh(Ph)(MeOH) and 
(TPP)Rh(OMe)(MeOH) (bottom of eq. 4.3). This is the first report of a (por)Rh(OMe) 
structure (Figure 4.6). 
 
Figure 4.6.  Molecular structures of (TPP)Rh(Ph)(CH3OH) (left ; 82% occupancy) and 
(TPP)Rh(CH3O)(CH3OH) (right; 18% occupancy) in the same crystal. Hydrogen atoms 
have been omitted for clarity except these on the OMe and MeOH group. 
	  
 Throughout the whole preparation, methanol was involved only in the 
crystallization step as a solvent, thus, it is likely that the (TPP)Rh(OMe) was formed 
through the reaction of unreacted Rh2(CO4)TPP with methanol during the process of 
crystallization. (eq. 4.1, bottom). The 1H NMR spectrum of this crystal in CDCl3 
displayed a signal at -5.72 ppm, which was assigned to the methoxy ligand.  
Curiously, we ordered “(TPP)Rh” and “(OEP)RhCl” from a reputable chemical 
supplier. I had extreme difficulty over several months characterizing several derivatives 
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that I generated using these purchased materials. I then re-characterized these 
commercial samples and found them to be, surprisingly, (TPP)Rh(C6H4Cl) and 
(OEP)Rh(CH2Cl), instead of what we initially ordered.  
Crystals of (TPP)Rh(C6H4Cl)(MeOH) were obtained from a solution of the 
compound in CH2Cl2/MeOH, and its structure was determined by X-ray crystallography 
(Figure 4.7). The occupancies of the disordered Cl atoms at the para and meta positions 
of the ligand were refined to be 0.872(3) and 0.128(3), respectively, which are 
consistent with the result from an 1H NMR spectroscopy study of the complex.  
Crystals of the five-coordinate (OEP)Rh(CH2Cl) formed from a solution of the 
compound in CH2Cl2/MeOH/hexane. The crystal structure (Figure 4.8) displayed a Rh-
C distance of 2.015(7) Å, which is similar to the Rh-C distance of 2.010(4) Å in the 
related (TPP)Rh(CH2Cl) structure published by Collman.22 However, in the structure of 
(TPP)Rh(CH2Cl), the β carbon atoms on the porphyrin displayed a large distortion with 
a maximum displacement of 0.484 Å to the 24-atom mean porphyrin plane. The closest 
Rh-Rh distance and the interporphyrin separation in (TPP)Rh(CH2Cl) are 5.32 and 3.67 
Å, respectively. In our structure of (OEP)Rh(CH2Cl), the porphyrin is more “flat” 
(Figure 4.8, middle). The two distances above mentioned are shortened by 0.7 and 0.4 
Å, respectively. An interporphyrin separation distance of 3.32 Å indicates a strong 
porphyrin π-π stacking (Figure 4.8, bottom) between the adjacent porphyrins in the 
structure of (OEP)Rh(CH2Cl).  
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Figure 4.7. (Top) Molecular structure of (TPP)Rh(C6H4Cl)(MeOH). Hydrogen atoms 
have been omitted for clarity except those on MeOH. The Cl atom was disordered at 
two positions. (Bottom) Perpendicular atom displacements (in units of 0.01 Å) of the 










Figure 4.8. (Top) Molecular structure of (TPP)Rh(CH2Cl). Hydrogen atoms have been 
omitted for clarity except those on the CH2Cl group. (Middle) Perpendicular atom 
displacements (in units of 0.01 Å) of the porphyrin core atoms from the 24-atom mean 
porphyrin plane. (Bottom) A diagram showing the distance of 3.32 Å between adjacent 
porphyrin macrocycles.  
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The UV-vis and 1H NMR spectral data of the cobalt and rhodium porphyrins 
described in this chapter are listed in Table 4.1 and Figure 4.9, respectively. These data 
are consistent with the literature values.  
Table 4.1. Selected UV-vis spectral data of synthesized and characterized 
Rh(III)/Co(III) porphyrins in CH2Cl2.  
 
Compound Peak position,  λ (nm)  
(This work) 
Peak position,  λ (nm)  
(Ref) 
(TPP)RhCl  422, 533, 568  
(TPP)Rh(C6H4Cl) 413, 521, 634  
(TPP)Rh(C6H5) 412, 520, 548 413, 520, 54817 
(OEP)Rh(CH2Cl)  394, 511, 543  
(TPP)Co(n-Bu)                408, 531          409, 53116 
 
The 1H NMR spectra displayed peaks, as expected, due to the porphyrin 
macrocycle and the axial ligands in these diamagnetic complexes. The 1H signals of the 
ligands coordinated to the metals are upfield from the normal region of the 
uncoordinated ligand, which results from the ring current effect of the aromatic 
porphyrin macrocycles.23 The ring current effect decreases with distance. As expected, 
the signal of H4 of the butyl group of (TPP)Co(n-Bu) shifted less than the H3. 
However, it is interesting to note that the H2 of (TPP)Co(n-Bu) resonates at higher field 
than the H1. This observation is consistent with the NMR spectra of other previously 
reported five-coordinate alkyl cobalt porphyrin complexes. It is likely resulted from the 
agnostic interaction between C2-H2-Co.  
Also, the 1H NMR spectrum of (TPP)Rh(Ph) displayed pyr-H signal at a 
chemical shift of 8.68 ppm. In comparison, the pyr-H was observed at a higher chemical 
shift at 8.75 ppm for (TPP)Rh(p-C6H4Cl), which parallels the better electron donating 
ability of the phenyl ligand. The aryl ligand, as a σ-donor, enhances the Rh to porphyrin 
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π-bonding and results in the increasing shielding of the porphyrin protons. The better 
electron donating ability of the axial ligand will lead to an increased shielding of the 
porphyrin. This cis-effect was previously observed for the alkylmetalloporphyrins with 
metals in d6 configuration.24 Furthermore, although not shown in Scheme 4.1, the 1H 
NMR spectrum of (TPP)Rh(C6H4Cl) indicated that it is a mixture of two isomers, 
(TPP)Rh(p-C6H4Cl) (β-pyr, 8.75 ppm)  and (TPP)Rh(m-C6H4Cl) (β-pyr, 8.76 ppm),17 
and (TPP)Rh(p- C6H4Cl) was the major component in this mixture, which is consistent 
with the results from X-ray crystallography studies.  
 
 
Figure 4.9.  1H NMR spectral data of selected rhodium/cobalt porphyrins in CDCl3. 
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4.3.2 The reaction of (TPP)Rh(R) with NO in solution 
The reactivity of NO gas with the σ-bonded aryl rhodium porphyrins, 
(TPP)Rh(C6H4Cl) and (TPP)Rh(Ph), was studied by infrared spectroscopy in CH2Cl2, as 
described in the experimental section. Addition of NO to (TPP)Rh(Ph) changes the 
color of the solution from bright orange to dark red over a period of 25 min. Excess NO 
was then removed by displacement of the headspace with N2. The product was quickly 
transferred by an air-tight syringe to a glass vial equipped with a mid-IR fiber-optic dip 
probe. The IR spectrum of the product solution displayed two new peaks at 1758 and 
1712 cm-1, along with a shoulder at 1637 cm-1 (Figure 4.10).  The multiple new peaks in 
the solution IR spectrum were indicative of perhaps a not-so-straightforward reaction 
product. The shoulder at 1637 cm-1 is close to the reported vNO of a putative 
(TPP)Rh(NO) at 1630 cm-1.11 
                           
Figure 4.10. The IR spectra (CH2Cl2) showing the formation of new peaks at 1758, 
1712 and 1637(sh) cm-1 when (TPP)Rh(Ph) was reacted with NO in solution.   
	  
Crystallization of this product from the slow evaporation of a CH2Cl2/hexane 
solution of the product in a glove box resulted in the formation of violet block shaped 
crystals over a period of two days. The X-ray crystallography was used to characterize 
the product which turned out to be a mixture of (TPP)Rh(Ph) (starting material) and the 
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bis-β-nitrated ((NO2)2TPP)Rh(Ph) complexes. The formation of ((NO2)2TPP)Rh(Ph) 
was completely unexpected, and may result from the attack of an in-situ generated NOx 
species on the porphyrin. The formation of the nitro groups was also indicative in the 
IR(KBr) spectrum of the crystals, judged by the increase of peak intensity at 1262 cm-1. 
11 
 The structure of ((NO2)2TPP)Rh(Ph) is shown in Figure 4.11. It is not 
surprising that the porphyrin macrocycle displays a large “saddled” distortion25 after the 
nitration of the porphyrin at the β positions (Figure 4.11, middle), with a largest 
displacement of 0.52 Å from the 24-atom mean porphyrin plane being that of a non-
nitrated pyrrole C-atom. Interestingly, we observed an unusual short distance between 
the Rh and the pyrrole-Cs on an adjacent porphyrin (Figure 4.11, bottom), which may 
lead to or result from the large distortion of the porphyrin macrocyle. The C=C double 
bonds are located in the “axial” position of the metal, indicating a possible but weak 
C=C π-interaction with the metal center.  
A similar reaction of (TPP)Rh(C6H4Cl) with NO gas in CH2Cl2 also resulted in 
the formation of IR bands at 1758 and 1712 cm-1, but all attempts to grow crystals from 











Figure 4.11. (Top) Molecular structure of ((NO2)2TPP)Rh(Ph). Hydrogen atoms have 
been omitted for clarity. (Middle) Perpendicular atom displacements (in units of 0.01 Å) 
of the porphyrin core atoms from the 24-atom mean porphyrin plane. (Bottom) The 
short distance between the Rh and the pyrrole-Cs on an adjacent porphyrin. 
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4.3.3 The reactions with NO gas in crystals: a solid-gas method 
Soaking crystals of metallooporphyrins in an atmosphere of NO gas could allow 
NO to diffuse into the crystals and coordinate with the metal centers of the porphyrins, 
if the space between porphyrin molecules is large enough to allow unhindered NO 
diffusion. This method has been successfully utilized by a former group member (Dr. 
Nan Xu), to obtain the first structures of previously inaccessible (por)Fe(NO)(thiolate)4 
and (por)Fe(NO)(O-ligand) complexes.3 The solid-gas method is especially useful to 
prepare nitrosyl metal porphyrin derivatives that are unstable in solution precluding 
crystallization from solution. The reactions of NO with (por)Rh(R) in solution discussed 
previously is complicated, and resulted in the isolation of the unexpected nitrated 
porphyrin as the product. Thus, the solid-gas method was attempted here to obtain the 
(por)Rh(NO)X products.  
Soaking crystals of the five-coordinate Rh/Co porphyrins ((TPP)Co(n-Bu), 
(TPP)Rh(Ph), (OEP)Rh(CH2Cl)) with NO gas did not result in the formation of the 
nitrosyl metal derivatives. As discussed earlier, the five-coordinate Rh/Co porphyrin 
complexes are usually packed tightly in crystals with short intermolecular distances 
(Figures 4.3, 4.5, 4.8), which probably disfavor an incoming sixth (NO) ligand.  
However, soaking crystals of (TPP)Co(n-Bu) with NO for two weeks resulted in 
the formation of new IR bands at 1683 and 1634 cm-1 along with an increase of peak 
intensity at 1462 cm-1. The peak at 1683 cm-1 is indicative of the formation of the 
known (TPP)CoNO,10 accompanied by the dissociation of butyl group.  The peaks at 
1634 and 1462 cm-1 indicate the formation of a derivative that has not yet been 
identified.  
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In contrast, the use of the six-coordinate (por)Rh(X)(solvent) precursors in these 
NO-soaking experiments allowed for the formation of the desired (por)Rh(NO)X 
derivatives. (TPP)Rh(Cl)(MeOH) was used to obtain (TPP)Rh(NO)Cl, and 
(TPP)Rh(Ph)(MeOH) was used to obtain (TPP)Rh(NO)(Ph). The structures of 
(TPP)Rh(NO)(Cl) and (TPP)Rh(NO)(Ph) are shown in Figure 4.12 and Figure 4.13.  
Selected bond lengths (Å) and bond angles (o) for the precursor Rh(III) porphyrins and 
their NO adducts are listed in Table 4.2.  
Table 4.2. Selected bond lengths (Å) and bond angles (o) in the structures of precursor 






Rh-N(O) Rh-N-O ΔRh* 
(TPP)Rh(Cl)(CH3OH) 2.031 (6) 2.305 (19)    4 
(TPP)Rh(Ph) 2.022 (4) 2.000 (5) 
1.993 (5) 
  11 




   0 
(TPP)Rh(C6H4Cl)(CH3OH)  1.997 (4)    7 



























* The displacement of Rh towards aryl/chloro ligand.  
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Figure 4.12. (Top) Molecular structure of (TPP)Rh(NO)Cl. Hydrogen atoms have been 
omitted for clarity. The oxygen atom was disordered over two positions. (Bottom) 
Perpendicular atom displacements (in units of 0.01 Å) of the porphyrin core atoms from 






                                        
                                 
Figure 4.13. (Top) Molecular structure of molecule B in (TPP)Rh(NO)(Ph). Hydrogen 
atoms have been omitted for clarity. (Middle) Perpendicular atom displacements (in 
units of 0.01 Å) of the porphyrin core atoms from the 24-atom mean porphyrin plane. 
(Bottom) Relative orientation of molecules A and B in the unit cell.  
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There are two unique molecules in the unit cell of (TPP)Rh(NO)(Ph), namely 
molecule A and molecule B (Figure 4.13, bottom). The Rh-C distances and the bond 
angles of Rh-N-O are slightly different for these two molecules (Table 4.2). A short 
intermolecular distance of 2.5 Å was observed between the C26A atom on the phenyl 
ligand of molecule A and the C atom on the phenyl group on the meso-pyrrole position 
of molecule B (Figure 4.13, bottom). This close distance between two phenyl groups 
likely led to the disorder of these meso-phenyl groups of molecule B. It could also affect 
the orientation of the phenyl ligand on molecule A to result in the differences in Rh-C 
distances in these two molecules.  
Several interesting features of these two six-coordinate nitrosyl rhodium 
porphyrin complexes are worthy of note. First, upon NO bonding, the previously 
saddled porphyrin macrocyle of (TPP)Rh(Cl)(MeOH) changed to a near-planar 
conformation (Figures 4.1 and 4.12). Changing to a more flat porphyrin macrocycle 
with NO binding was also observed in the crystal structure of (TPP)Rh(NO)(Ph) 
(Figures 4.4 and 4.13 ). Second, the Rh-N(O) distances in the structures of 
(TPP)Rh(NO)(Cl) and (TPP)Rh(NO)(Ph) were refined to be 2.202(11) and 2.310(13) Å, 
respectively. These bond lengths are rather long and suggest that the NO molecules are 
only weakly coordinated to the metal centers. More importantly, this experimental 
result is consistent with other DFT calculations from our group (not shown).  
Also, the RhNO moiety in (TPP)Rh(NO)Cl is bent with an angle of 123.6(16)o, 
while the RhNO moiety in (TPP)Rh(Ph)(NO) is bent with an angle of 106.1o(17) and 
115o(14) for molecules A and B, respectively (Scheme 4.1). These values are also 
unexpected. In the structure of five-coordinate nitrosyl iron (II) porphyrin, the Fe-N-O 
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displayed an angle of approximately 140 o. In general, (por)M(NO)X porphyrins that 
are formally {MNO} 7 expected to have M-N-O angle of ~140o.26 In my structures, 
these angles are significantly decreased by ~20 o (Scheme 4.2). It could be a result from 
the very weak Rh-N(O) bonds that place these compounds as “exceptions” to the 
normal cases.   
        
 
Scheme 4.1. The bond distances and angles of some formally {MNO} 7 nitrosyl metal 
porphyrins. 
	  
In the work of our previous group member (Dr. Nan Xu), the solid-state 
structure of six-coordinate (OEP)Fe(NO)(S-2,6-(CF3CONH)2C6H3] compound displays 
an unusual bent Fe-N-O linkage (159.6o),4 while the (TPP)Fe(NO)(OCOCF3) compound 
displays an expected near liner conformation of the Fe-N-O moiety,3 as shown on the 
left side of Scheme 4.2. A following DFT calculation by Lehnert revealed that the 
differences in bond angles are due to the differences in σ-trans effects of the 
coordinated ligands. In our work, a similar trend was also observed. The Rh-N-O 
moiety in (TPP)Rh(NO)(Ph) is more bent than the one in (TPP)Rh(NO)(Cl). 
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Scheme 4.2. The nitrosyl metal porphyrins with different ligands showing different 
bonding angles. 
	  
The weak Rh-N(O) bond and the ease of oxidation of (por)Rh(NO)(R) in air 
resulted in difficulties in obtaining reliable IR spectra of the complexes.11 The IR 
spectrum (KBr) of crystals of (TPP)Rh(NO)(Cl) displayed the formation of  weak peaks 
at 1731, 1397 and 1261 cm-1, along with the significant increase of peak at 1538 cm-1. 
The formation of new peaks in the range from 1500 to 1200 cm-1 indicate oxidation of 
the bound NO to nitrite in the presence of trace air (O2) when recording the IR 
spectrum.27 The same phenomenon was also observed for the IR spectrum of 
(TPP)Rh(NO)(Ph) where I observed the formation of new peaks at 1811, 1397 and 1321 
cm-1 and an increase of peak intensity at 1595 cm-1. 
To my surprise, exposing crystals of (TPP)Rh(C6H4Cl) to NO gas for two weeks 
led to a completely unexpected result. The structure of the product was determined, by 
X-ray crystallography, to be a mixture of (TPP)Rh(N(=O)C6H4Cl) and 
(TPP)Rh(C6H4Cl)(CH2Cl2) (Figure 4.14). Instead of binding to the metal center at the 
trans position as observed in the structures described above, NO had selectively 
inserted in the metal-carbon bonds of some of the molecules in the crystal to result in 
the formation of a C-nitroso rhodium porhyrin complex, with an N=O distance of 
1.223(15) Å.  
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Figure 4.14. (Top) Molecular structures of (TPP)Rh(C6H4Cl)(CH2Cl2) (left) and 
(TPP)Rh(N(=O)C6H4Cl) (right) in the same crystal. Hydrogen atoms have been omitted 
for clarity. (Bottom) Perpendicular atom displacements (in units of 0.01 Å) of the 
porphyrin core atoms from the 24-atom mean porphyrin plane of 
(TPP)Rh(C6H4Cl)(CH2Cl2) (left) and (TPP)Rh(N(=O)C6H4Cl) (right). 
	  
Curiously, the chloro substituent on the aryl ring of the axial ligand had 
(formally) migrated to the ortho position in the C-nitroso product (Figure 4.14, right). 
This migration of Cl atom may play an important role in the NO insertion. However, it 
is important to note that the crystals we used to obtain the structure of the precursor 
compound ((TPP)Rh(C6H4Cl)(MeOH)) and the crystals used for NO soaking are not 
from the same batch of crystals. Although those two batches of crystals were 
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crystallized under the same conditions, we are hesitant to compare their structures and 
over-interpret the structural differences.  
The IR (KBr) spectrum of the NO-soaked crystals left in the vial displayed the 
formation of a new peak at 1414 cm-1, which was assigned to the vNO stretching 
frequency of the C-nitroso ligand (Figure 4.15). It is in the same range as the vNO 
stretching frequencies (1330~1500 cm-1) reported for the other C-nitroso metal 
porphyrin complexes.28-30 
                         
Figure 4.15. The infrared spectrum of the crystal containing (TPP)Rh(NOC6H4Cl) 
highlighting the formation of a new band at 1414 cm-1.  
	  
Our group is still working on the mechanism of this unusual NO insertion. 
Generally, there are two possible ways for NO insertion into a metal-carbon bond, 









Proposal (a) is a migratory insertion reaction; proposal (b) involves the photo-
cleavage of the rhodium-carbon bond, which will consequently generate an organic 
radical and a porphyrin rhodium (II). Since the reaction is happening in a crystal, due to 
a sterically unfavorable coordination of a Rh(o-C6H4Cl) species, NO might 
preferentially attack at the ortho position of the chlorobenzene radical, which results in 
the formation of C-nitroso compound and the migration of the Cl atom in the final 
product.  
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In summary, I managed to prepare and structurally characterize the first set of 
rhodium nitrosyl porphyrins (TPP)Rh(NO)Cl and (TPP)Rh(NO)Ph using a “solid-gas 
NO soaking” method in this work.3,4 X-ray crystallography was used to determine 
accurate geometries of the Rh-N-O linkage, which were found to deviate significantly 
from what was predicted in the literature. The unexpected long Rh-N(O) bond lengths 
of ~2.2 Å could signify weak interactions between NO and these group 9 
metalloporphyrins, placing them in a “non-classical” set of (por)M(NO)X systems. In 
addition, for the reaction between NO and the crystals of (TPP)Rh(C6H4Cl), I observed 
the first reported NO insertion into a metal-carbon bond in a porphyrin system, to result 
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